| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | FRAS1 RELN VWF LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 TECTA ZP3 FBN2 IGFBP7 ACAN BMPER MUC2 AGRN FBN3 | 4.37e-17 | 188 | 117 | 18 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | FRAS1 RELN VWF KRTAP3-3 POTEF KRT85 LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 TECTA ZP3 FBN2 IGFBP7 ACAN JAG1 KRTAP3-2 KRTAP3-1 KRTAP24-1 BMPER MUC2 AGRN FBN3 | 8.18e-12 | 891 | 117 | 26 | GO:0005198 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.07e-05 | 8 | 117 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | Notch binding | 1.77e-05 | 27 | 117 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.28e-05 | 10 | 117 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.37e-05 | 29 | 117 | 4 | GO:0043395 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | RELN ESR2 WNT10B WNT11 WNT9B DGKQ SEMA5A ZP3 CARTPT FBN2 JAG1 FST AGRN | 6.62e-05 | 616 | 117 | 13 | GO:0030545 |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.08e-04 | 20 | 117 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.26e-04 | 51 | 117 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | BMP binding | 2.78e-04 | 22 | 117 | 3 | GO:0036122 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | RELN WNT10B WNT11 WNT9B DGKQ SEMA5A ZP3 CARTPT FBN2 JAG1 AGRN | 4.15e-04 | 554 | 117 | 11 | GO:0030546 |
| GeneOntologyMolecularFunction | calcium ion binding | SPOCK1 SVEP1 EGFEM1P SCUBE1 FBN2 MEGF6 ACAN JAG1 DLL3 USP32 SCUBE3 AGRN FBN3 | 4.48e-04 | 749 | 117 | 13 | GO:0005509 |
| GeneOntologyMolecularFunction | scavenger receptor activity | 5.18e-04 | 27 | 117 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 5.75e-04 | 65 | 117 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 8.92e-04 | 73 | 117 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.03e-03 | 268 | 117 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | syndecan binding | 1.19e-03 | 9 | 117 | 2 | GO:0045545 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 1.42e-03 | 547 | 117 | 10 | GO:0048018 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.57e-03 | 85 | 117 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | frizzled binding | 1.91e-03 | 42 | 117 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.16e-03 | 12 | 117 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.18e-03 | 44 | 117 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 2.55e-03 | 13 | 117 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 2.55e-03 | 13 | 117 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.95e-03 | 323 | 117 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.96e-03 | 14 | 117 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | integrin binding | 3.71e-03 | 175 | 117 | 5 | GO:0005178 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | ERBB4 RAPGEF6 KRT85 ESR2 WNT10B WNT11 WNT9B LAMA1 LAMB2 LAMC1 TECTA LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F SCUBE1 JAG1 CHRD FST MUC2 | 2.80e-09 | 870 | 116 | 22 | GO:0030855 |
| GeneOntologyBiologicalProcess | epithelium development | FRAS1 ERBB4 RAPGEF6 KRT85 ESR2 WNT10B WNT11 WNT9B LAMA1 LAMB2 LAMC1 SEMA5A TECTA LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F SCUBE1 JAG1 ATP2C2 DLL3 CHRD BMPER FST MUC2 PCNT | 7.59e-09 | 1469 | 116 | 28 | GO:0060429 |
| GeneOntologyBiologicalProcess | epidermis development | KRT85 WNT10B LAMB3 LAMC1 LAMC2 TECTA LCE1C LCE1B LCE1E LCE1A SVEP1 LCE3A LCE1F JAG1 FST | 4.83e-08 | 461 | 116 | 15 | GO:0008544 |
| GeneOntologyBiologicalProcess | axon guidance | EPHB2 ERBB2 RELN LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 AGRN | 7.37e-08 | 285 | 116 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | EPHB2 ERBB2 RELN LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 AGRN | 7.66e-08 | 286 | 116 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 3.04e-07 | 11 | 116 | 4 | GO:0110011 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EPHB2 FRAS1 ERBB4 ESR2 WNT10B WNT11 WNT9B LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 ADAMTS5 TECTA FBN2 ACAN JAG1 FST MEGF11 PCNT | 5.23e-07 | 1269 | 116 | 23 | GO:0009887 |
| GeneOntologyBiologicalProcess | keratinization | 5.98e-07 | 87 | 116 | 7 | GO:0031424 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 9.10e-07 | 14 | 116 | 4 | GO:2001046 | |
| GeneOntologyBiologicalProcess | skin development | FRAS1 KRT85 WNT10B LAMC1 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F JAG1 FST | 1.30e-06 | 373 | 116 | 12 | GO:0043588 |
| GeneOntologyBiologicalProcess | axon development | EPHB2 ERBB2 RELN POTEF LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 SCARF1 AGRN | 3.19e-06 | 642 | 116 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB2 ERBB2 RELN POTEF LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 AGRN | 3.63e-06 | 566 | 116 | 14 | GO:0007409 |
| GeneOntologyBiologicalProcess | basement membrane organization | 4.19e-06 | 43 | 116 | 5 | GO:0071711 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 4.72e-06 | 284 | 116 | 10 | GO:0009913 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 7.74e-06 | 23 | 116 | 4 | GO:2001044 | |
| GeneOntologyBiologicalProcess | central nervous system development | EPHB2 ATRN SETD1A ERBB2 RELN ERBB4 SALL3 SPOCK1 ESR2 WNT9B LAMB2 SEMA5A LAMC3 LHX6 ADGRA2 ACAN DLL3 CHRD KCNQ2 PCNT | 1.09e-05 | 1197 | 116 | 20 | GO:0007417 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.17e-05 | 189 | 116 | 8 | GO:0030216 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB2 ERBB2 RELN POTEF LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 TECTA AGRN | 1.97e-05 | 748 | 116 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | establishment of planar polarity involved in nephron morphogenesis | 3.14e-05 | 2 | 116 | 2 | GO:0072046 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | OLFML2B LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 SEMA5A ADAMTS5 ACAN ADAMTS15 | 5.40e-05 | 377 | 116 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | OLFML2B LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 SEMA5A ADAMTS5 ACAN ADAMTS15 | 5.52e-05 | 378 | 116 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | OLFML2B LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 SEMA5A ADAMTS5 ACAN ADAMTS15 | 5.65e-05 | 379 | 116 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 9.81e-05 | 131 | 116 | 6 | GO:0030510 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 1.12e-04 | 84 | 116 | 5 | GO:1903053 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.26e-04 | 338 | 116 | 9 | GO:0045165 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 ERBB2 RELN POTEF LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 AGRN | 1.66e-04 | 802 | 116 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 ERBB2 RELN SALL3 SPOCK1 POTEF LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 TECTA LHX6 SCARF1 KCNQ2 AGRN | 1.80e-04 | 1463 | 116 | 20 | GO:0048666 |
| GeneOntologyBiologicalProcess | myoblast development | 1.87e-04 | 4 | 116 | 2 | GO:0048627 | |
| GeneOntologyBiologicalProcess | regulation of synaptic activity | 1.87e-04 | 4 | 116 | 2 | GO:0060025 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 ERBB2 RELN POTEF LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 AGRN | 2.05e-04 | 819 | 116 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB2 ERBB2 RELN POTEF LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 AGRN | 2.24e-04 | 826 | 116 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | sensory organ development | EPHB2 WNT10B WNT9B LAMA1 LAMB2 LAMC3 TECTA KMT2C IGFBP7 JAG1 BMPER MEGF11 PCNT | 2.37e-04 | 730 | 116 | 13 | GO:0007423 |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 2.78e-04 | 56 | 116 | 4 | GO:0001941 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB4 signaling pathway | 3.10e-04 | 5 | 116 | 2 | GO:0038135 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | EPHB2 RELN ERBB4 WNT11 LAMA1 LAMA2 NTNG1 SEMA5A LAMC2 ADGRA2 ZP3 FBN2 ACAN JAG1 CHRD BMPER MUC2 | 4.30e-04 | 1211 | 116 | 17 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of locomotion | EPHB2 RELN ERBB4 WNT11 LAMA1 LAMA2 NTNG1 SEMA5A LAMC2 ADGRA2 ZP3 FBN2 ACAN JAG1 CHRD BMPER MUC2 AGRN | 4.33e-04 | 1327 | 116 | 18 | GO:0040012 |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 4.84e-04 | 176 | 116 | 6 | GO:0007224 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 5.20e-04 | 410 | 116 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cerebral cortex tangential migration | 6.46e-04 | 7 | 116 | 2 | GO:0021800 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 6.82e-04 | 124 | 116 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 6.83e-04 | 426 | 116 | 9 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 7.65e-04 | 192 | 116 | 6 | GO:0045667 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | EPHB2 RELN ERBB4 WNT11 LAMA1 LAMA2 NTNG1 SEMA5A LAMC2 ADGRA2 ZP3 FBN2 ACAN JAG1 CHRD BMPER MUC2 | 8.03e-04 | 1280 | 116 | 17 | GO:2000145 |
| GeneOntologyBiologicalProcess | neuron maturation | 8.07e-04 | 74 | 116 | 4 | GO:0042551 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | WNT10B LAMA1 LAMA2 LAMB2 LAMC1 ADAMTS5 FBXO22 DPF3 ADAMTS15 MEGF10 | 8.36e-04 | 531 | 116 | 10 | GO:0042692 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 ERBB2 RELN SPOCK1 POTEF LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 TECTA SCARF1 AGRN | 8.38e-04 | 1285 | 116 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 8.49e-04 | 75 | 116 | 4 | GO:0022617 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 8.74e-04 | 131 | 116 | 5 | GO:0032526 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 8.74e-04 | 197 | 116 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 9.21e-04 | 199 | 116 | 6 | GO:0051147 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FRAS1 ERBB4 ESR2 WNT11 WNT9B LAMA1 LAMC1 SEMA5A ADAMTS5 JAG1 CHRD FST | 1.06e-03 | 750 | 116 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 1.08e-03 | 80 | 116 | 4 | GO:0030514 | |
| GeneOntologyBiologicalProcess | brain development | EPHB2 ATRN SETD1A RELN ERBB4 SALL3 ESR2 WNT9B SEMA5A LHX6 CHRD KCNQ2 PCNT | 1.09e-03 | 859 | 116 | 13 | GO:0007420 |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 FRAS1 RELN VWF OLFML2B WNT11 LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 MUC5B ADAMTS5 TECTA ZP3 SVEP1 FBN2 MEGF6 IGFBP7 ACAN ADAMTS15 BMPER MUC2 AGRN FBN3 | 1.02e-16 | 656 | 113 | 27 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 FRAS1 RELN VWF OLFML2B WNT11 LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 MUC5B ADAMTS5 TECTA ZP3 SVEP1 FBN2 MEGF6 IGFBP7 ACAN ADAMTS15 BMPER MUC2 AGRN FBN3 | 1.10e-16 | 658 | 113 | 27 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMB4 FRAS1 RELN VWF LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 ADAMTS5 ZP3 FBN2 MEGF6 IGFBP7 ACAN ADAMTS15 BMPER MUC2 AGRN | 8.32e-13 | 530 | 113 | 21 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | LAMB4 FRAS1 LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 ACAN AGRN | 5.96e-11 | 122 | 113 | 11 | GO:0005604 |
| GeneOntologyCellularComponent | keratin filament | KRTAP3-3 KRT85 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 | 1.21e-10 | 97 | 113 | 10 | GO:0045095 |
| GeneOntologyCellularComponent | laminin complex | 1.04e-09 | 10 | 113 | 5 | GO:0043256 | |
| GeneOntologyCellularComponent | intermediate filament | MICAL1 KRTAP3-3 KRT85 KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 | 3.78e-09 | 227 | 113 | 12 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | MICAL1 KRTAP3-3 KRT85 KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 | 1.96e-08 | 263 | 113 | 12 | GO:0045111 |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.82e-06 | 17 | 113 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.68e-05 | 59 | 113 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.93e-05 | 33 | 113 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | neuromuscular junction | 3.28e-05 | 112 | 113 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | laminin-11 complex | 8.66e-05 | 3 | 113 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-1 complex | 8.66e-05 | 3 | 113 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | laminin-3 complex | 8.66e-05 | 3 | 113 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.73e-04 | 4 | 113 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | supramolecular fiber | MICAL1 KRTAP3-3 POTEF KRT85 KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 FBXO22 FBN2 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 FBN3 PCNT | 1.96e-04 | 1179 | 113 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MICAL1 KRTAP3-3 POTEF KRT85 KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 FBXO22 FBN2 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 FBN3 PCNT | 2.13e-04 | 1187 | 113 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MICAL1 KRTAP3-3 POTEF KRT85 KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 PCNT | 3.51e-04 | 899 | 113 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | microfibril | 2.17e-03 | 13 | 113 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.91e-03 | 109 | 113 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | node of Ranvier | 5.16e-03 | 20 | 113 | 2 | GO:0033268 | |
| HumanPheno | Focal automatism seizure | 2.50e-06 | 12 | 45 | 4 | HP:0032898 | |
| MousePheno | abnormal somatic sensory system morphology | EPHB2 ERBB2 RELN ERBB4 SALL3 CRIM1 ESR2 TMEM63B LAMA2 LAMB2 LAMC3 TECTA SCUBE1 ACAN JAG1 DLL3 CHRD FST MEGF11 DISP1 MEGF10 | 1.02e-09 | 702 | 86 | 21 | MP:0000959 |
| MousePheno | abnormal somatic nervous system morphology | EPHB2 ERBB2 RELN ERBB4 SALL3 CRIM1 ESR2 TMEM63B LAMA2 LAMB2 LAMC3 TECTA SCUBE1 FBN2 ACAN JAG1 DLL3 CHRD FST AGRN MEGF11 DISP1 MEGF10 | 3.38e-08 | 1025 | 86 | 23 | MP:0002752 |
| MousePheno | perinatal lethality, complete penetrance | ERBB2 SALL3 KMT2B CRIM1 WNT11 LAMB3 LAMC1 ADGRA2 BIRC6 KMT2C SCUBE1 ACAN CHRD KCNQ2 BMPER FST AGRN DISP1 | 2.51e-07 | 712 | 86 | 18 | MP:0011089 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | ERBB2 FRAS1 SALL3 KMT2B CRIM1 WNT11 LAMB2 LAMB3 LAMC1 LAMC2 CHD4 LHX6 ADGRA2 BIRC6 KMT2C SCUBE1 ACAN CHRD KCNQ2 BMPER FST AGRN DISP1 PCNT | 3.95e-07 | 1269 | 86 | 24 | MP:0011111 |
| MousePheno | perinatal lethality | ERBB2 SALL3 KMT2B CRIM1 WNT11 WNT9B LAMA2 LAMB3 LAMC1 CHD4 ADGRA2 BIRC6 KMT2C SCUBE1 ACAN CHRD KCNQ2 BMPER FST AGRN DISP1 | 3.37e-06 | 1130 | 86 | 21 | MP:0002081 |
| MousePheno | abnormal basement membrane morphology | 4.35e-06 | 40 | 86 | 5 | MP:0004272 | |
| MousePheno | abnormal basal lamina morphology | 4.44e-06 | 6 | 86 | 3 | MP:0004273 | |
| MousePheno | abnormal sensory neuron morphology | EPHB2 ERBB2 RELN ERBB4 ESR2 LAMA2 LAMB2 LAMC3 ACAN JAG1 FST MEGF11 MEGF10 | 5.90e-06 | 473 | 86 | 13 | MP:0000965 |
| MousePheno | abnormal sensory neuron innervation pattern | 2.12e-05 | 92 | 86 | 6 | MP:0000968 | |
| MousePheno | neonatal lethality, complete penetrance | SALL3 WNT11 LAMB3 LAMC1 ADGRA2 BIRC6 SCUBE1 ACAN KCNQ2 BMPER FST AGRN DISP1 | 2.15e-05 | 534 | 86 | 13 | MP:0011087 |
| MousePheno | syndactyly | 2.26e-05 | 93 | 86 | 6 | MP:0000564 | |
| MousePheno | abnormal innervation | 2.41e-05 | 193 | 86 | 8 | MP:0002184 | |
| MousePheno | abnormal thoracic cage morphology | SETD1A FRAS1 CRIM1 FBN2 ACAN ATP2C2 DLL3 SCUBE3 CHRD BMPER FST PCNT | 2.50e-05 | 463 | 86 | 12 | MP:0004624 |
| MousePheno | abnormal rib morphology | 2.79e-05 | 257 | 86 | 9 | MP:0000150 | |
| MousePheno | abnormal ear morphology | ESR2 TMEM63B LAMA2 LAMC2 MUC5B TECTA FBN2 ACAN JAG1 SCUBE3 CHRD BMPER | 2.90e-05 | 470 | 86 | 12 | MP:0002102 |
| MousePheno | abnormal limb morphology | FRAS1 CRIM1 ESR2 TMEM63B LAMC1 LAMC2 ADAMTS5 SVEP1 FBN2 ZSCAN10 ACAN DLL3 SCUBE3 BMPER FST AGRN DISP1 PCNT | 4.33e-05 | 1028 | 86 | 18 | MP:0002109 |
| MousePheno | abnormal digestive system morphology | EPHB2 FRAS1 RELN VWF SALL3 CRIM1 ESR2 WNT10B WNT9B LAMB3 IREB2 LAMC2 ADGRA2 CARTPT ACAN JAG1 CHRD FST DISP1 PCNT | 4.46e-05 | 1233 | 86 | 20 | MP:0000462 |
| MousePheno | abnormal temporal bone morphology | 5.21e-05 | 66 | 86 | 5 | MP:0005272 | |
| MousePheno | abnormal nervous system development | EPHB2 ERBB2 RELN ERBB4 KMT2B WNT10B LAMA2 LAMC1 LHX6 ADGRA2 SCUBE1 JAG1 DLL3 CHRD ANKMY2 BMPER FST AGRN DISP1 PCNT | 5.86e-05 | 1257 | 86 | 20 | MP:0003861 |
| MousePheno | abnormal synaptic transmission | SETD1A RELN ERBB4 SPOCK1 CTC1 ESR2 LAMA2 LAMB2 MUC5B LHX6 FBXO22 ZSCAN10 NRXN2 DPF3 CHRD KCNQ2 CACNA1G AGRN | 7.30e-05 | 1070 | 86 | 18 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | SETD1A RELN ERBB4 SPOCK1 CTC1 ESR2 LAMA2 LAMB2 MUC5B LHX6 FBXO22 ZSCAN10 NRXN2 DPF3 CHRD KCNQ2 CACNA1G AGRN | 7.84e-05 | 1076 | 86 | 18 | MP:0021009 |
| MousePheno | neonatal lethality | SALL3 WNT11 WNT9B LAMB3 LAMC1 CHD4 ADGRA2 BIRC6 SCUBE1 ACAN KCNQ2 BMPER FST AGRN DISP1 | 9.64e-05 | 799 | 86 | 15 | MP:0002058 |
| MousePheno | abnormal palate morphology | 1.55e-04 | 321 | 86 | 9 | MP:0003755 | |
| MousePheno | abnormal geniculate ganglion morphology | 1.72e-04 | 18 | 86 | 3 | MP:0001082 | |
| MousePheno | limbs/digits/tail phenotype | FRAS1 CRIM1 ESR2 TMEM63B LAMC1 LAMC2 ADAMTS5 SVEP1 FBXO22 FBN2 ZSCAN10 ACAN DLL3 SCUBE3 BMPER FST AGRN DISP1 PCNT | 1.86e-04 | 1258 | 86 | 19 | MP:0005371 |
| MousePheno | abnormal craniofacial morphology | FRAS1 SALL3 CRIM1 WNT9B LAMA2 LAMB3 LAMC2 ADGRA2 SCUBE1 FBN2 ACAN JAG1 DLL3 SCUBE3 CHRD ANKMY2 BMPER FST DISP1 PCNT | 1.96e-04 | 1372 | 86 | 20 | MP:0000428 |
| MousePheno | craniofacial phenotype | FRAS1 SALL3 CRIM1 WNT9B LAMA2 LAMB3 LAMC2 ADGRA2 SCUBE1 FBN2 ACAN JAG1 DLL3 SCUBE3 CHRD ANKMY2 BMPER FST DISP1 PCNT | 1.96e-04 | 1372 | 86 | 20 | MP:0005382 |
| MousePheno | abnormal cartilage morphology | 2.17e-04 | 336 | 86 | 9 | MP:0000163 | |
| MousePheno | abnormal glomerular filtration barrier function | 2.23e-04 | 4 | 86 | 2 | MP:0011856 | |
| MousePheno | fetal bleb | 2.23e-04 | 4 | 86 | 2 | MP:0008856 | |
| MousePheno | digestive/alimentary phenotype | EPHB2 HGFAC FRAS1 RELN VWF SALL3 CRIM1 ESR2 WNT10B WNT9B LAMB3 IREB2 LAMC2 ADGRA2 CARTPT ACAN JAG1 CHRD FST DISP1 PCNT | 2.29e-04 | 1500 | 86 | 21 | MP:0005381 |
| MousePheno | abnormal glial cell morphology | 2.64e-04 | 345 | 86 | 9 | MP:0003634 | |
| MousePheno | abnormal CNS glial cell morphology | 2.65e-04 | 272 | 86 | 8 | MP:0000952 | |
| MousePheno | abnormal temporal bone squamous part morphology | 2.76e-04 | 21 | 86 | 3 | MP:0004423 | |
| MousePheno | delayed kidney development | 2.76e-04 | 21 | 86 | 3 | MP:0000528 | |
| MousePheno | renal glomerulus cyst | 2.76e-04 | 21 | 86 | 3 | MP:0011682 | |
| MousePheno | abnormal neuron differentiation | 2.85e-04 | 275 | 86 | 8 | MP:0009937 | |
| MousePheno | abnormal CNS synaptic transmission | SETD1A RELN ERBB4 SPOCK1 CTC1 ESR2 LAMA2 MUC5B LHX6 FBXO22 ZSCAN10 NRXN2 DPF3 CHRD KCNQ2 AGRN | 2.92e-04 | 985 | 86 | 16 | MP:0002206 |
| MousePheno | abnormal trigeminal ganglion morphology | 3.59e-04 | 55 | 86 | 4 | MP:0001092 | |
| MousePheno | absent vas deferens | 3.70e-04 | 5 | 86 | 2 | MP:0003557 | |
| MousePheno | absent uterus | 3.70e-04 | 5 | 86 | 2 | MP:0003558 | |
| MousePheno | small cricoid cartilage | 3.70e-04 | 5 | 86 | 2 | MP:0030872 | |
| MousePheno | abnormal interdigital cell death | 3.70e-04 | 5 | 86 | 2 | MP:0009874 | |
| MousePheno | abnormal extracellular matrix morphology | 3.73e-04 | 100 | 86 | 5 | MP:0013258 | |
| MousePheno | hearing/vestibular/ear phenotype | EPHB2 ESR2 TMEM63B LAMA2 IREB2 LAMC2 MUC5B TECTA FBN2 ACAN JAG1 ADAMTS15 SCUBE3 CHRD BMPER | 3.75e-04 | 905 | 86 | 15 | MP:0005377 |
| MousePheno | abnormal cranium morphology | FRAS1 CRIM1 LAMA2 LAMB3 LAMC2 SCUBE1 FBN2 ACAN DLL3 SCUBE3 CHRD BMPER FST DISP1 | 4.11e-04 | 813 | 86 | 14 | MP:0000438 |
| MousePheno | decreased rib number | 4.11e-04 | 57 | 86 | 4 | MP:0003345 | |
| MousePheno | abnormal ureteric bud morphology | 4.11e-04 | 57 | 86 | 4 | MP:0006032 | |
| MousePheno | kinked neural tube | 4.11e-04 | 57 | 86 | 4 | MP:0003400 | |
| MousePheno | blistering | 4.14e-04 | 24 | 86 | 3 | MP:0001208 | |
| MousePheno | intracranial hemorrhage | 4.47e-04 | 104 | 86 | 5 | MP:0001915 | |
| MousePheno | abnormal neuron number | 4.76e-04 | 456 | 86 | 10 | MP:0008946 | |
| MousePheno | abnormal craniofacial bone morphology | FRAS1 CRIM1 LAMA2 LAMB3 LAMC2 SCUBE1 FBN2 ACAN DLL3 SCUBE3 CHRD BMPER FST DISP1 | 4.88e-04 | 827 | 86 | 14 | MP:0002116 |
| MousePheno | abnormal pectoral girdle bone morphology | 5.21e-04 | 301 | 86 | 8 | MP:0004508 | |
| MousePheno | abnormal inner ear morphology | 5.44e-04 | 303 | 86 | 8 | MP:0000026 | |
| MousePheno | abnormal mechanoreceptor morphology | 5.45e-04 | 231 | 86 | 7 | MP:0000972 | |
| MousePheno | abnormal oropharynx morphology | 5.52e-04 | 6 | 86 | 2 | MP:0002252 | |
| MousePheno | abnormal cumulus oophorus morphology | 5.52e-04 | 6 | 86 | 2 | MP:0009372 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 5.52e-04 | 6 | 86 | 2 | MP:0001054 | |
| MousePheno | small thyroid cartilage | 5.52e-04 | 6 | 86 | 2 | MP:0030867 | |
| MousePheno | decreased bone mineral content | WNT10B LAMC2 LCE1C LCE1B LCE1E LCE1A ZSCAN10 MEGF6 DPF3 SCUBE3 | 5.55e-04 | 465 | 86 | 10 | MP:0010124 |
| MousePheno | abnormal autopod morphology | 6.45e-04 | 390 | 86 | 9 | MP:0000572 | |
| MousePheno | abnormal vertebral arch morphology | 7.04e-04 | 174 | 86 | 6 | MP:0004599 | |
| MousePheno | abnormal laryngeal cartilage morphology | 7.32e-04 | 29 | 86 | 3 | MP:0002256 | |
| MousePheno | abnormal joint morphology | 7.32e-04 | 397 | 86 | 9 | MP:0002932 | |
| MousePheno | abnormal intervertebral disk morphology | 7.62e-04 | 67 | 86 | 4 | MP:0004173 | |
| MousePheno | abnormal nasopharynx morphology | 7.70e-04 | 7 | 86 | 2 | MP:0002251 | |
| MousePheno | decreased renal glomerulus number | 8.09e-04 | 30 | 86 | 3 | MP:0004505 | |
| MousePheno | abnormal digit morphology | 8.27e-04 | 323 | 86 | 8 | MP:0002110 | |
| MousePheno | abnormal kidney cortex morphology | 8.44e-04 | 324 | 86 | 8 | MP:0000521 | |
| MousePheno | abnormal amacrine cell morphology | 8.92e-04 | 31 | 86 | 3 | MP:0005240 | |
| MousePheno | abnormal cerebral cortex morphology | 9.13e-04 | 328 | 86 | 8 | MP:0000788 | |
| MousePheno | abnormal symphysis morphology | 9.48e-04 | 71 | 86 | 4 | MP:0030877 | |
| MousePheno | abnormal basicranium morphology | 9.59e-04 | 123 | 86 | 5 | MP:0010029 | |
| MousePheno | absent vestibular hair cells | 1.02e-03 | 8 | 86 | 2 | MP:0004325 | |
| MousePheno | abnormal retina inner limiting membrane morphology | 1.02e-03 | 8 | 86 | 2 | MP:0010235 | |
| MousePheno | increased secondary ovarian follicle number | 1.02e-03 | 8 | 86 | 2 | MP:0031383 | |
| MousePheno | abnormal respiration | ERBB2 FRAS1 LAMA2 LAMC2 MUC5B ZSCAN10 ACAN SCUBE3 BMPER FST DISP1 | 1.06e-03 | 598 | 86 | 11 | MP:0001943 |
| MousePheno | increased total body fat amount | 1.16e-03 | 424 | 86 | 9 | MP:0010024 | |
| MousePheno | abnormal axial skeleton morphology | SETD1A FRAS1 SALL3 CRIM1 LAMA2 LAMB3 IREB2 LAMC2 SCUBE1 FBN2 ACAN ATP2C2 DLL3 SCUBE3 CHRD BMPER FST DISP1 PCNT | 1.17e-03 | 1458 | 86 | 19 | MP:0002114 |
| MousePheno | abnormal cardiovascular development | ERBB2 ERBB4 KMT2B CRIM1 SEMA5A CHD4 ADGRA2 BIRC6 JAG1 CHRD ANKMY2 DISP1 PCNT | 1.18e-03 | 802 | 86 | 13 | MP:0002925 |
| MousePheno | abnormal renal glomerulus morphology | 1.19e-03 | 264 | 86 | 7 | MP:0005325 | |
| MousePheno | abnormal dermomyotome development | 1.31e-03 | 9 | 86 | 2 | MP:0004206 | |
| MousePheno | dermal-epidermal separation | 1.31e-03 | 9 | 86 | 2 | MP:0011160 | |
| MousePheno | abnormal bone mineral content | ATRN WNT10B LAMC2 LCE1C LCE1B LCE1E LCE1A FBN2 ZSCAN10 MEGF6 DPF3 SCUBE3 | 1.34e-03 | 713 | 86 | 12 | MP:0010122 |
| MousePheno | hindlimb paresis | 1.50e-03 | 37 | 86 | 3 | MP:0031204 | |
| MousePheno | decreased neuronal precursor cell number | 1.50e-03 | 37 | 86 | 3 | MP:0004981 | |
| MousePheno | abnormal Schwann cell morphology | 1.50e-03 | 37 | 86 | 3 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 1.50e-03 | 37 | 86 | 3 | MP:0001105 | |
| MousePheno | abnormal cochlear hair cell morphology | 1.52e-03 | 202 | 86 | 6 | MP:0002622 | |
| MousePheno | abnormal bone structure | ATRN SETD1A ESR2 WNT10B LAMC2 LCE1C LCE1B LCE1E LCE1A CARTPT FBN2 ZSCAN10 MEGF6 DPF3 ACAN DLL3 SCUBE3 FST | 1.59e-03 | 1379 | 86 | 18 | MP:0003795 |
| MousePheno | abnormal pharynx morphology | 1.62e-03 | 38 | 86 | 3 | MP:0002234 | |
| MousePheno | absent cochlear outer hair cells | 1.63e-03 | 10 | 86 | 2 | MP:0004403 | |
| MousePheno | abnormal skeleton development | 1.68e-03 | 447 | 86 | 9 | MP:0002113 | |
| MousePheno | microphthalmia | 1.71e-03 | 362 | 86 | 8 | MP:0001297 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 1.72e-03 | 207 | 86 | 6 | MP:0003308 | |
| MousePheno | abnormal prepulse inhibition | SETD1A RELN ERBB4 SPOCK1 CTC1 MUC5B FBXO22 ZSCAN10 DPF3 KCNQ2 | 1.77e-03 | 542 | 86 | 10 | MP:0003088 |
| MousePheno | abnormal vascular development | 1.77e-03 | 542 | 86 | 10 | MP:0000259 | |
| MousePheno | abnormal organ of Corti morphology | 1.81e-03 | 209 | 86 | 6 | MP:0000042 | |
| MousePheno | abnormal cartilaginous joint morphology | 1.85e-03 | 85 | 86 | 4 | MP:0030875 | |
| Domain | EGF | ATRN HGFAC FRAS1 RELN LAMA1 LAMA2 NTNG1 LAMB2 LAMC1 LAMC2 LAMC3 TECTA SVEP1 SCARF1 ITGBL1 SCUBE1 FBN2 MEGF6 NRXN2 ATRNL1 JAG1 DLL3 SCUBE3 AGRN MEGF11 FBN3 MEGF10 | 7.66e-27 | 235 | 116 | 27 | SM00181 |
| Domain | EGF_2 | EPHB2 ATRN HGFAC LAMB4 RELN LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 SVEP1 SCARF1 ITGBL1 SCUBE1 FBN2 MEGF6 NRXN2 ATRNL1 JAG1 DLL3 SCUBE3 AGRN MEGF11 FBN3 MEGF10 | 8.44e-27 | 265 | 116 | 28 | PS01186 |
| Domain | Laminin_EGF | ATRN LAMB4 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 SCARF1 MEGF6 ATRNL1 AGRN MEGF11 MEGF10 | 3.32e-26 | 38 | 116 | 16 | IPR002049 |
| Domain | EGF-like_dom | ATRN HGFAC FRAS1 RELN LAMA1 LAMA2 NTNG1 LAMB2 LAMC1 LAMC2 LAMC3 TECTA SVEP1 SCARF1 ITGBL1 SCUBE1 FBN2 MEGF6 NRXN2 ATRNL1 JAG1 DLL3 SCUBE3 AGRN MEGF11 FBN3 MEGF10 | 3.75e-26 | 249 | 116 | 27 | IPR000742 |
| Domain | EGF_1 | ATRN HGFAC LAMB4 RELN LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 SVEP1 SCARF1 ITGBL1 SCUBE1 FBN2 MEGF6 NRXN2 ATRNL1 JAG1 DLL3 SCUBE3 AGRN MEGF11 FBN3 MEGF10 | 7.19e-26 | 255 | 116 | 27 | PS00022 |
| Domain | EGF_Lam | ATRN LAMB4 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 MEGF6 ATRNL1 AGRN MEGF11 MEGF10 | 9.05e-25 | 35 | 116 | 15 | SM00180 |
| Domain | Laminin_EGF | ATRN LAMB4 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 SCARF1 MEGF6 AGRN MEGF11 MEGF10 | 9.05e-25 | 35 | 116 | 15 | PF00053 |
| Domain | EGF-like_CS | ATRN HGFAC LAMB4 RELN LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 SVEP1 SCARF1 SCUBE1 FBN2 MEGF6 NRXN2 ATRNL1 JAG1 DLL3 SCUBE3 AGRN MEGF11 FBN3 MEGF10 | 3.18e-24 | 261 | 116 | 26 | IPR013032 |
| Domain | Growth_fac_rcpt_ | EPHB2 ATRN ERBB2 FRAS1 ERBB4 CRIM1 LAMA1 LAMB2 LAMC1 LAMC2 LAMC3 SVEP1 SCARF1 SCUBE1 FBN2 MEGF6 IGFBP7 JAG1 DLL3 SCUBE3 FBN3 | 1.87e-22 | 156 | 116 | 21 | IPR009030 |
| Domain | EGF_LAM_2 | ATRN LAMB4 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 ATRNL1 AGRN | 1.45e-19 | 30 | 116 | 12 | PS50027 |
| Domain | EGF_LAM_1 | ATRN LAMB4 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 ATRNL1 AGRN | 1.45e-19 | 30 | 116 | 12 | PS01248 |
| Domain | EGF_3 | ATRN HGFAC RELN NTNG1 SVEP1 SCARF1 SCUBE1 FBN2 MEGF6 NRXN2 ATRNL1 JAG1 DLL3 SCUBE3 AGRN MEGF11 FBN3 MEGF10 | 6.13e-15 | 235 | 116 | 18 | PS50026 |
| Domain | Laminin_N | 2.14e-14 | 16 | 116 | 8 | IPR008211 | |
| Domain | LamNT | 2.14e-14 | 16 | 116 | 8 | SM00136 | |
| Domain | LAMININ_NTER | 2.14e-14 | 16 | 116 | 8 | PS51117 | |
| Domain | Laminin_N | 2.14e-14 | 16 | 116 | 8 | PF00055 | |
| Domain | EGF_extracell | ATRN RELN SVEP1 SCARF1 ITGBL1 MEGF6 ATRNL1 JAG1 DLL3 MEGF11 MEGF10 | 8.68e-14 | 60 | 116 | 11 | IPR013111 |
| Domain | EGF_2 | ATRN RELN SVEP1 SCARF1 ITGBL1 MEGF6 ATRNL1 JAG1 DLL3 MEGF11 MEGF10 | 8.68e-14 | 60 | 116 | 11 | PF07974 |
| Domain | VWC | 1.41e-12 | 38 | 116 | 9 | SM00214 | |
| Domain | VWF_dom | 3.77e-12 | 42 | 116 | 9 | IPR001007 | |
| Domain | hEGF | 4.86e-12 | 28 | 116 | 8 | PF12661 | |
| Domain | VWC_out | 1.41e-11 | 19 | 116 | 7 | SM00215 | |
| Domain | VWFC_2 | 7.26e-11 | 38 | 116 | 8 | PS50184 | |
| Domain | EGF | ATRN HGFAC TECTA SVEP1 MEGF6 NRXN2 JAG1 DLL3 SCUBE3 AGRN FBN3 | 3.66e-10 | 126 | 116 | 11 | PF00008 |
| Domain | LAMININ_IVA | 4.67e-10 | 8 | 116 | 5 | PS51115 | |
| Domain | Laminin_B | 4.67e-10 | 8 | 116 | 5 | PF00052 | |
| Domain | LamB | 4.67e-10 | 8 | 116 | 5 | SM00281 | |
| Domain | Laminin_IV | 4.67e-10 | 8 | 116 | 5 | IPR000034 | |
| Domain | LCE | 5.90e-10 | 17 | 116 | 6 | PF14672 | |
| Domain | LCE | 5.90e-10 | 17 | 116 | 6 | IPR028205 | |
| Domain | VWFC_1 | 2.14e-09 | 36 | 116 | 7 | PS01208 | |
| Domain | C8 | 6.48e-09 | 12 | 116 | 5 | PF08742 | |
| Domain | TIL | 6.48e-09 | 12 | 116 | 5 | PF01826 | |
| Domain | Keratin_matx | 7.03e-09 | 5 | 116 | 4 | IPR007659 | |
| Domain | Unchr_dom_Cys-rich | 1.05e-08 | 13 | 116 | 5 | IPR014853 | |
| Domain | C8 | 1.05e-08 | 13 | 116 | 5 | SM00832 | |
| Domain | TIL_dom | 1.62e-08 | 14 | 116 | 5 | IPR002919 | |
| Domain | SPRR/LCE | 1.70e-08 | 28 | 116 | 6 | IPR026075 | |
| Domain | VWC | 1.70e-08 | 28 | 116 | 6 | PF00093 | |
| Domain | VWF_type-D | 3.50e-08 | 16 | 116 | 5 | IPR001846 | |
| Domain | VWFD | 3.50e-08 | 16 | 116 | 5 | PS51233 | |
| Domain | VWD | 3.50e-08 | 16 | 116 | 5 | SM00216 | |
| Domain | VWD | 3.50e-08 | 16 | 116 | 5 | PF00094 | |
| Domain | EGF_CA | 6.82e-08 | 122 | 116 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.85e-08 | 124 | 116 | 9 | IPR001881 | |
| Domain | Galactose-bd-like | 1.24e-07 | 94 | 116 | 8 | IPR008979 | |
| Domain | Keratin_B2_2 | 1.39e-07 | 39 | 116 | 6 | PF13885 | |
| Domain | Keratin_matx | 2.33e-07 | 3 | 116 | 3 | PF04579 | |
| Domain | Ephrin_rec_like | 4.51e-07 | 11 | 116 | 4 | PF07699 | |
| Domain | Keratin_matx | 9.30e-07 | 4 | 116 | 3 | PD010562 | |
| Domain | EGF_CA | 1.06e-06 | 86 | 116 | 7 | PF07645 | |
| Domain | KAP | 1.57e-06 | 58 | 116 | 6 | IPR002494 | |
| Domain | EGF_Ca-bd_CS | 2.41e-06 | 97 | 116 | 7 | IPR018097 | |
| Domain | EGF_CA | 2.76e-06 | 99 | 116 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.95e-06 | 100 | 116 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.36e-06 | 106 | 116 | 7 | IPR000152 | |
| Domain | Keratin_B2 | 4.69e-06 | 40 | 116 | 5 | PF01500 | |
| Domain | Ephrin_rec_like | 1.62e-05 | 25 | 116 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.62e-05 | 25 | 116 | 4 | IPR011641 | |
| Domain | cEGF | 1.90e-05 | 26 | 116 | 4 | PF12662 | |
| Domain | cEGF | 1.90e-05 | 26 | 116 | 4 | IPR026823 | |
| Domain | TB_dom | 1.91e-05 | 9 | 116 | 3 | IPR017878 | |
| Domain | TB | 1.91e-05 | 9 | 116 | 3 | PS51364 | |
| Domain | Laminin_G_1 | 3.71e-05 | 11 | 116 | 3 | PF00054 | |
| Domain | Kazal_2 | 7.14e-05 | 36 | 116 | 4 | PF07648 | |
| Domain | LAM_G_DOMAIN | 8.86e-05 | 38 | 116 | 4 | PS50025 | |
| Domain | - | 9.09e-05 | 73 | 116 | 5 | 2.60.120.260 | |
| Domain | Laminin_IV_B | 1.14e-04 | 3 | 116 | 2 | IPR013015 | |
| Domain | LAMININ_IVB | 1.14e-04 | 3 | 116 | 2 | PS51116 | |
| Domain | FBN | 1.14e-04 | 3 | 116 | 2 | IPR011398 | |
| Domain | Post-SET_dom | 1.23e-04 | 16 | 116 | 3 | IPR003616 | |
| Domain | EMI_domain | 1.23e-04 | 16 | 116 | 3 | IPR011489 | |
| Domain | PostSET | 1.23e-04 | 16 | 116 | 3 | SM00508 | |
| Domain | POST_SET | 1.23e-04 | 16 | 116 | 3 | PS50868 | |
| Domain | EMI | 1.49e-04 | 17 | 116 | 3 | PS51041 | |
| Domain | LamG | 1.58e-04 | 44 | 116 | 4 | SM00282 | |
| Domain | CTCK_1 | 1.78e-04 | 18 | 116 | 3 | PS01185 | |
| Domain | Furin_repeat | 1.78e-04 | 18 | 116 | 3 | IPR006212 | |
| Domain | FU | 1.78e-04 | 18 | 116 | 3 | SM00261 | |
| Domain | KAZAL | 1.88e-04 | 46 | 116 | 4 | SM00280 | |
| Domain | Wnt | 2.10e-04 | 19 | 116 | 3 | IPR005817 | |
| Domain | WNT1 | 2.10e-04 | 19 | 116 | 3 | PS00246 | |
| Domain | Wnt_CS | 2.10e-04 | 19 | 116 | 3 | IPR018161 | |
| Domain | wnt | 2.10e-04 | 19 | 116 | 3 | PF00110 | |
| Domain | WNT1 | 2.10e-04 | 19 | 116 | 3 | SM00097 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 2.28e-04 | 4 | 116 | 2 | IPR016245 | |
| Domain | CUB | 2.41e-04 | 49 | 116 | 4 | PF00431 | |
| Domain | KAZAL_2 | 2.61e-04 | 50 | 116 | 4 | PS51465 | |
| Domain | CUB | 2.61e-04 | 50 | 116 | 4 | SM00042 | |
| Domain | Kazal_dom | 2.82e-04 | 51 | 116 | 4 | IPR002350 | |
| Domain | - | 3.04e-04 | 52 | 116 | 4 | 2.60.120.290 | |
| Domain | - | 3.15e-04 | 95 | 116 | 5 | 2.60.120.200 | |
| Domain | CUB | 3.27e-04 | 53 | 116 | 4 | PS01180 | |
| Domain | CT | 3.30e-04 | 22 | 116 | 3 | SM00041 | |
| Domain | FYrich_C | 3.78e-04 | 5 | 116 | 2 | IPR003889 | |
| Domain | FYrich_N | 3.78e-04 | 5 | 116 | 2 | IPR003888 | |
| Domain | FYRC | 3.78e-04 | 5 | 116 | 2 | SM00542 | |
| Domain | FYRN | 3.78e-04 | 5 | 116 | 2 | SM00541 | |
| Domain | DSL | 3.78e-04 | 5 | 116 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 3.78e-04 | 5 | 116 | 2 | IPR011651 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP3-3 KRT85 LCE1C LCE1B LCE1E KRTAP5-5 LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 | 1.04e-13 | 217 | 97 | 17 | M27640 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB2 ERBB2 RELN KRTAP3-3 KRT85 WNT10B WNT11 WNT9B LAMA1 SREBF1 LAMA2 LAMC1 SEMA5A CHD4 LCE1C LCE1B LCE1E KRTAP5-5 LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KMT2C ZSCAN10 DPF3 JAG1 KRTAP3-2 KRTAP3-1 DLL3 KCNQ2 CACNA1G KRTAP24-1 KRTAP5-2 AGRN | 2.22e-13 | 1432 | 97 | 37 | M509 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | LAMB4 RELN VWF LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 AGRN | 1.12e-11 | 84 | 97 | 11 | M7098 |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.08e-11 | 11 | 97 | 6 | M158 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | VWF LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 ADAMTS5 SCUBE1 FBN2 ACAN SCUBE3 AGRN FBN3 CAPN15 | 2.00e-10 | 300 | 97 | 16 | M610 |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 7.89e-10 | 46 | 97 | 8 | M239 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.05e-09 | 30 | 97 | 7 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.05e-09 | 30 | 97 | 7 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.23e-09 | 59 | 97 | 8 | M27218 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP3-3 KRT85 KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 | 7.66e-09 | 153 | 97 | 11 | MM15343 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.09e-08 | 41 | 97 | 7 | M27778 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | LAMB3 LAMC1 LAMC2 ADAMTS5 SCUBE1 FBN2 ACAN SCUBE3 FBN3 CAPN15 | 4.07e-08 | 140 | 97 | 10 | M587 |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.55e-08 | 79 | 97 | 8 | M27643 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 8.65e-08 | 33 | 97 | 6 | M39503 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.06e-07 | 84 | 97 | 8 | M3228 | |
| Pathway | KEGG_FOCAL_ADHESION | LAMB4 ERBB2 RELN VWF LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 | 1.16e-07 | 199 | 97 | 11 | M7253 |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.03e-07 | 96 | 97 | 8 | M39834 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.28e-07 | 66 | 97 | 7 | MM15925 | |
| Pathway | WP_FOCAL_ADHESION | 6.14e-07 | 187 | 97 | 10 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 1.09e-06 | 199 | 97 | 10 | M39402 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB2 ERBB2 RELN KRTAP3-3 KRT85 SEMA5A KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 | 1.60e-06 | 502 | 97 | 15 | MM14537 |
| Pathway | WP_CANCER_PATHWAYS | LAMB4 ERBB2 ESR2 WNT10B WNT11 WNT9B LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 JAG1 DLL3 | 1.81e-06 | 507 | 97 | 15 | M48302 |
| Pathway | KEGG_PATHWAYS_IN_CANCER | LAMB4 ERBB2 WNT10B WNT11 WNT9B LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 | 2.27e-06 | 325 | 97 | 12 | M12868 |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.91e-06 | 66 | 97 | 6 | M18 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.35e-05 | 76 | 97 | 6 | M27219 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.96e-05 | 129 | 97 | 7 | M27649 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 4.26e-05 | 302 | 97 | 10 | M39719 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 5.63e-05 | 60 | 97 | 5 | M40048 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.04e-05 | 258 | 97 | 9 | MM14572 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 7.40e-05 | 33 | 97 | 4 | M39455 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.07e-05 | 326 | 97 | 10 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.12e-04 | 339 | 97 | 10 | M39736 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.33e-04 | 114 | 97 | 6 | MM14571 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.66e-04 | 16 | 97 | 3 | M47424 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.54e-04 | 143 | 97 | 6 | M27275 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 6.29e-04 | 57 | 97 | 4 | M48326 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 6.51e-04 | 25 | 97 | 3 | MM14940 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 7.32e-04 | 26 | 97 | 3 | M27239 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | WNT10B WNT11 LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 KMT2C | 8.67e-04 | 439 | 97 | 10 | M42563 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.24e-04 | 109 | 97 | 5 | MM15164 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 9.62e-04 | 7 | 97 | 2 | M47805 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | HGFAC ERBB2 ERBB4 LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 CHD4 | 1.05e-03 | 532 | 97 | 11 | M27870 |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.12e-03 | 30 | 97 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.12e-03 | 30 | 97 | 3 | MM15812 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.22e-03 | 68 | 97 | 4 | M27303 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.23e-03 | 31 | 97 | 3 | MM1343 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.32e-03 | 118 | 97 | 5 | M39852 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.63e-03 | 9 | 97 | 2 | M47866 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.91e-03 | 36 | 97 | 3 | M39699 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 2.03e-03 | 10 | 97 | 2 | MM1545 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.41e-03 | 39 | 97 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.41e-03 | 39 | 97 | 3 | MM15165 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 2.48e-03 | 11 | 97 | 2 | M27372 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 2.48e-03 | 11 | 97 | 2 | MM15478 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 2.48e-03 | 11 | 97 | 2 | MM14760 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 2.79e-03 | 85 | 97 | 4 | M48315 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 2.96e-03 | 12 | 97 | 2 | M22020 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.99e-03 | 42 | 97 | 3 | M48018 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 2.99e-03 | 42 | 97 | 3 | M39703 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 2.99e-03 | 42 | 97 | 3 | MM15822 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 3.41e-03 | 44 | 97 | 3 | MM15878 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 3.48e-03 | 13 | 97 | 2 | M27729 | |
| Pathway | REACTOME_NEPHRON_DEVELOPMENT | 3.48e-03 | 13 | 97 | 2 | M48245 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 3.48e-03 | 13 | 97 | 2 | M47423 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 3.48e-03 | 13 | 97 | 2 | MM15320 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 3.64e-03 | 45 | 97 | 3 | M39571 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 3.87e-03 | 46 | 97 | 3 | M48243 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 3.87e-03 | 46 | 97 | 3 | MM15971 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 4.04e-03 | 14 | 97 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 4.04e-03 | 14 | 97 | 2 | MM14531 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.11e-03 | 47 | 97 | 3 | M7946 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 4.20e-03 | 154 | 97 | 5 | M39739 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 4.64e-03 | 15 | 97 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 4.64e-03 | 15 | 97 | 2 | M27608 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.64e-03 | 15 | 97 | 2 | M27161 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 5.06e-03 | 161 | 97 | 5 | M39770 | |
| Pubmed | 6.29e-16 | 18 | 119 | 8 | 11311202 | ||
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.50e-15 | 11 | 119 | 7 | 23472759 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.50e-15 | 11 | 119 | 7 | 21524702 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.89e-14 | 15 | 119 | 7 | 15895400 | |
| Pubmed | 5.12e-14 | 16 | 119 | 7 | 17601529 | ||
| Pubmed | 5.98e-14 | 29 | 119 | 8 | 22613833 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | FRAS1 OLFML2B LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 AGRN | 1.77e-13 | 79 | 119 | 10 | 18757743 |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | VWF OLFML2B LAMA1 LAMA2 LAMB2 LAMC1 ADAMTS5 SVEP1 ITGBL1 IGFBP7 ACAN BMPER FST AGRN | 1.85e-13 | 248 | 119 | 14 | 24006456 |
| Pubmed | 2.93e-13 | 10 | 119 | 6 | 9034910 | ||
| Pubmed | 3.43e-13 | 20 | 119 | 7 | 22911573 | ||
| Pubmed | FRAS1 VWF LAMA1 LAMA2 LAMB2 LAMB3 LAMC1 LAMC2 IGFBP7 BMPER MUC2 AGRN | 6.13e-13 | 167 | 119 | 12 | 22159717 | |
| Pubmed | 1.28e-12 | 12 | 119 | 6 | 9396756 | ||
| Pubmed | 2.86e-12 | 26 | 119 | 7 | 24742657 | ||
| Pubmed | 1.01e-10 | 22 | 119 | 6 | 15854049 | ||
| Pubmed | KRTAP3-3 KRTAP5-5 KRTAP10-7 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 | 1.04e-10 | 69 | 119 | 8 | 18721477 | |
| Pubmed | 1.07e-10 | 10 | 119 | 5 | 11784026 | ||
| Pubmed | Renal collecting system growth and function depend upon embryonic γ1 laminin expression. | 1.36e-10 | 23 | 119 | 6 | 21903675 | |
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 1.36e-10 | 23 | 119 | 6 | 11698679 | |
| Pubmed | 5.33e-10 | 175 | 119 | 10 | 28071719 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A ERBB2 FRAS1 RAPGEF6 KMT2B CTC1 SREBF1 LAMB2 DGKQ LAMB3 LAMC3 ZNF865 ADGRA2 BIRC6 KMT2C MEGF6 KCNQ2 DTX2 AGRN PCNT | 1.16e-09 | 1105 | 119 | 20 | 35748872 |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 1.26e-09 | 15 | 119 | 5 | 12921739 | |
| Pubmed | 1.26e-09 | 15 | 119 | 5 | 9264260 | ||
| Pubmed | 1.94e-09 | 6 | 119 | 4 | 1678389 | ||
| Pubmed | 1.94e-09 | 6 | 119 | 4 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 1.94e-09 | 6 | 119 | 4 | 3794389 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 1.94e-09 | 6 | 119 | 4 | 3109910 | |
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 1.94e-09 | 6 | 119 | 4 | 23948589 | |
| Pubmed | 1.94e-09 | 6 | 119 | 4 | 2119632 | ||
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 1.94e-09 | 6 | 119 | 4 | 9506922 | |
| Pubmed | RELN SPOCK1 LAMA1 LAMB2 LAMB3 SEMA5A LAMC2 ADAMTS5 DLL3 CHRD | 3.12e-09 | 210 | 119 | 10 | 16537572 | |
| Pubmed | 3.56e-09 | 18 | 119 | 5 | 14730302 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 7921537 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 14557481 | ||
| Pubmed | 4.93e-09 | 40 | 119 | 6 | 27068110 | ||
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 9.02e-09 | 8 | 119 | 4 | 9489770 | |
| Pubmed | 9.02e-09 | 8 | 119 | 4 | 8872465 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 12122015 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.68e-08 | 26 | 119 | 5 | 34189436 | |
| Pubmed | 2.69e-08 | 10 | 119 | 4 | 15623520 | ||
| Pubmed | Expression of laminin chains during myogenic differentiation. | 3.91e-08 | 3 | 119 | 3 | 7510707 | |
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 18697739 | ||
| Pubmed | Laminin-121--recombinant expression and interactions with integrins. | 3.91e-08 | 3 | 119 | 3 | 20566382 | |
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 7698745 | ||
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 17426950 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 5.73e-08 | 30 | 119 | 5 | 24552588 | |
| Pubmed | 6.06e-08 | 153 | 119 | 8 | 25037231 | ||
| Pubmed | 6.31e-08 | 12 | 119 | 4 | 26794322 | ||
| Pubmed | 6.31e-08 | 12 | 119 | 4 | 16750824 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 6.82e-08 | 31 | 119 | 5 | 11431694 | |
| Pubmed | 9.01e-08 | 64 | 119 | 6 | 22261194 | ||
| Pubmed | 9.10e-08 | 13 | 119 | 4 | 36350252 | ||
| Pubmed | 9.10e-08 | 13 | 119 | 4 | 12682087 | ||
| Pubmed | 1.27e-07 | 14 | 119 | 4 | 36347239 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 8081888 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 2099832 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 15370542 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 32072250 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 29397434 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 8034675 | ||
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 2.30e-07 | 16 | 119 | 4 | 17948866 | |
| Pubmed | 2.30e-07 | 16 | 119 | 4 | 15028290 | ||
| Pubmed | 2.30e-07 | 16 | 119 | 4 | 17410201 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | ZNF775 KRT85 DGKQ LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-1 KRTAP5-2 | 2.70e-07 | 630 | 119 | 13 | 36949045 |
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 3.84e-07 | 18 | 119 | 4 | 23041440 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 11969289 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 7670489 | ||
| Pubmed | Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. | 3.89e-07 | 5 | 119 | 3 | 8719886 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 10964500 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 9719032 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 12743034 | ||
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 3.89e-07 | 5 | 119 | 3 | 8613743 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.43e-07 | 135 | 119 | 7 | 28675934 | |
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 7.45e-07 | 21 | 119 | 4 | 22767514 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 ATRN ERBB2 FRAS1 CRIM1 SPOCK1 LAMA1 SREBF1 LAMB2 LAMB3 LAMC1 LAMC3 FBXO22 FBN2 IGFBP7 BMPER AGRN | 7.46e-07 | 1201 | 119 | 17 | 35696571 |
| Pubmed | 7.52e-07 | 146 | 119 | 7 | 27068509 | ||
| Pubmed | Laminin regulates PDGFRβ(+) cell stemness and muscle development. | 7.75e-07 | 6 | 119 | 3 | 27138650 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 18254948 | ||
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 9441749 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 1.35e-06 | 7 | 119 | 3 | 9004048 | |
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 1.35e-06 | 7 | 119 | 3 | 9390664 | |
| Pubmed | Identification of the scaramanga gene implicates Neuregulin3 in mammary gland specification. | 1.35e-06 | 7 | 119 | 3 | 16140987 | |
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 8950511 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ATRN LAMB4 ZNF775 KMT2B LAMA1 LAMB3 BIRC6 KMT2C MEGF6 ADAMTS15 CHRD FBN3 MEGF10 | 1.53e-06 | 736 | 119 | 13 | 29676528 |
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 1.56e-06 | 25 | 119 | 4 | 17170699 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 22266653 | ||
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 2.16e-06 | 8 | 119 | 3 | 23529140 | |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 2.16e-06 | 8 | 119 | 3 | 23130995 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 9852162 | ||
| Pubmed | NPAS1 represses the generation of specific subtypes of cortical interneurons. | 2.90e-06 | 29 | 119 | 4 | 25467980 | |
| Pubmed | 3.23e-06 | 9 | 119 | 3 | 22665483 | ||
| Pubmed | 3.23e-06 | 9 | 119 | 3 | 9707552 | ||
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 3.33e-06 | 30 | 119 | 4 | 36305473 | |
| Pubmed | Sall1 balances self-renewal and differentiation of renal progenitor cells. | 3.51e-06 | 67 | 119 | 5 | 24550112 | |
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 4.35e-06 | 32 | 119 | 4 | 31434798 | |
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 4.61e-06 | 10 | 119 | 3 | 18590826 | |
| Pubmed | Postnatal prolongation of mammalian nephrogenesis by excess fetal GDNF. | 6.28e-06 | 35 | 119 | 4 | 34032268 | |
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 21084308 | ||
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 14962103 | ||
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 12051813 | ||
| Pubmed | A critical role for NF2 and the Hippo pathway in branching morphogenesis. | 7.05e-06 | 36 | 119 | 4 | 27480037 | |
| Interaction | HOXA1 interactions | ZNF843 VWF KRTAP3-3 ESR2 LAMB2 DGKQ LCE1C LCE1B LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 MEGF6 KRTAP3-2 CHRD KRTAP5-2 DTX2 FST AGRN | 1.30e-14 | 356 | 115 | 20 | int:HOXA1 |
| Interaction | LCE4A interactions | KRTAP3-3 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-2 KRTAP3-1 KRTAP5-2 | 2.88e-14 | 80 | 115 | 12 | int:LCE4A |
| Interaction | KRTAP4-11 interactions | KRTAP3-3 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 KRTAP3-1 KRTAP5-2 | 1.64e-13 | 92 | 115 | 12 | int:KRTAP4-11 |
| Interaction | LCE2B interactions | KRTAP3-3 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-1 KRTAP5-2 | 1.11e-12 | 81 | 115 | 11 | int:LCE2B |
| Interaction | KRTAP9-3 interactions | KRTAP3-3 WNT11 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP3-2 KRTAP3-1 CHRD KRTAP5-2 | 1.33e-12 | 140 | 115 | 13 | int:KRTAP9-3 |
| Interaction | LCE1B interactions | LCE1C LCE1B LCE1E LCE1A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP5-2 | 1.92e-12 | 85 | 115 | 11 | int:LCE1B |
| Interaction | KRTAP12-1 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 KRTAP3-2 CHRD | 2.44e-12 | 63 | 115 | 10 | int:KRTAP12-1 |
| Interaction | KRTAP10-1 interactions | KRTAP3-3 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 KRTAP3-2 CHRD KRTAP5-2 | 4.17e-12 | 153 | 115 | 13 | int:KRTAP10-1 |
| Interaction | LCE3B interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP5-2 | 4.31e-12 | 46 | 115 | 9 | int:LCE3B |
| Interaction | LCE1F interactions | KRTAP3-3 LCE1C LCE1B LCE1E LCE1A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-2 CHRD KRTAP5-2 | 4.68e-12 | 92 | 115 | 11 | int:LCE1F |
| Interaction | KRTAP5-6 interactions | KRTAP3-3 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 KRTAP5-2 | 5.95e-12 | 94 | 115 | 11 | int:KRTAP5-6 |
| Interaction | LCE2A interactions | LCE1C LCE1B LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 KRTAP3-2 KRTAP5-2 | 6.30e-12 | 69 | 115 | 10 | int:LCE2A |
| Interaction | KRTAP9-8 interactions | KRTAP3-3 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-1 KRTAP5-2 | 1.19e-11 | 100 | 115 | 11 | int:KRTAP9-8 |
| Interaction | KRTAP4-2 interactions | KRTAP3-3 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 CHRD KRTAP5-2 | 1.31e-11 | 132 | 115 | 12 | int:KRTAP4-2 |
| Interaction | KRTAP4-4 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-2 KRTAP5-2 | 3.29e-11 | 81 | 115 | 10 | int:KRTAP4-4 |
| Interaction | KRTAP5-2 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP5-2 | 7.35e-11 | 62 | 115 | 9 | int:KRTAP5-2 |
| Interaction | KRTAP5-4 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP5-2 | 8.54e-11 | 63 | 115 | 9 | int:KRTAP5-4 |
| Interaction | LCE5A interactions | LCE1C LCE1B LCE1E LCE1A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-1 CHRD KRTAP5-2 | 9.60e-11 | 90 | 115 | 10 | int:LCE5A |
| Interaction | KRTAP10-5 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 KRTAP3-2 CHRD KRTAP5-2 | 1.26e-10 | 160 | 115 | 12 | int:KRTAP10-5 |
| Interaction | KRTAP5-11 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP5-2 | 1.32e-10 | 66 | 115 | 9 | int:KRTAP5-11 |
| Interaction | KRTAP5-3 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP5-2 | 1.32e-10 | 66 | 115 | 9 | int:KRTAP5-3 |
| Interaction | LCE3C interactions | KRTAP3-3 LCE1B LCE1A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 KRTAP3-2 KRTAP5-2 | 1.51e-10 | 67 | 115 | 9 | int:LCE3C |
| Interaction | KRTAP5-7 interactions | 2.59e-10 | 71 | 115 | 9 | int:KRTAP5-7 | |
| Interaction | LCE2D interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP5-2 | 3.78e-10 | 74 | 115 | 9 | int:LCE2D |
| Interaction | KRTAP4-5 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP5-2 | 4.83e-10 | 76 | 115 | 9 | int:KRTAP4-5 |
| Interaction | SPRY1 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 KRTAP3-2 CHRD | 7.82e-10 | 111 | 115 | 10 | int:SPRY1 |
| Interaction | KRTAP9-2 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 KRTAP3-2 CHRD KRTAP5-2 | 9.16e-10 | 149 | 115 | 11 | int:KRTAP9-2 |
| Interaction | KRTAP10-8 interactions | ZNF775 WNT11 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 SCARF1 KRTAP3-2 KRTAP3-1 CHRD KRTAP5-2 ZNF669 | 1.12e-09 | 401 | 115 | 16 | int:KRTAP10-8 |
| Interaction | LCE1A interactions | LCE1C LCE1B LCE1E LCE1A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-2 KRTAP5-2 | 1.20e-09 | 84 | 115 | 9 | int:LCE1A |
| Interaction | LCE2C interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP5-2 | 1.83e-09 | 88 | 115 | 9 | int:LCE2C |
| Interaction | KRTAP5-9 interactions | WNT11 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP10-3 CHRD KRTAP5-2 | 1.96e-09 | 203 | 115 | 12 | int:KRTAP5-9 |
| Interaction | KRTAP4-12 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 KRTAP3-2 KRTAP3-1 CHRD | 2.09e-09 | 161 | 115 | 11 | int:KRTAP4-12 |
| Interaction | CREB5 interactions | KRT85 ESR2 LCE1C LCE1F KRTAP10-7 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP5-2 FST AGRN | 2.54e-09 | 164 | 115 | 11 | int:CREB5 |
| Interaction | KRTAP10-11 interactions | 2.98e-09 | 64 | 115 | 8 | int:KRTAP10-11 | |
| Interaction | LCE1E interactions | 4.88e-09 | 68 | 115 | 8 | int:LCE1E | |
| Interaction | CYSRT1 interactions | ZNF775 ZNF843 KRTAP3-3 KRT85 ESR2 WNT11 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 SCARF1 KRTAP3-1 CHRD ZNF669 | 5.01e-09 | 511 | 115 | 17 | int:CYSRT1 |
| Interaction | LCE1D interactions | 6.18e-09 | 70 | 115 | 8 | int:LCE1D | |
| Interaction | KRTAP12-3 interactions | KRTAP3-3 WNT11 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 CHRD | 1.14e-08 | 146 | 115 | 10 | int:KRTAP12-3 |
| Interaction | LCE1C interactions | 1.33e-08 | 77 | 115 | 8 | int:LCE1C | |
| Interaction | TRIM42 interactions | LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 KRTAP3-2 CHRD | 1.38e-08 | 149 | 115 | 10 | int:TRIM42 |
| Interaction | SMCP interactions | 1.64e-08 | 79 | 115 | 8 | int:SMCP | |
| Interaction | OTX1 interactions | KRTAP3-3 KRT85 LCE1C LCE1B LCE1F KRTAP10-7 KRTAP10-3 KRTAP3-2 KRTAP3-1 CHRD | 2.02e-08 | 155 | 115 | 10 | int:OTX1 |
| Interaction | KRTAP12-4 interactions | 2.03e-08 | 53 | 115 | 7 | int:KRTAP12-4 | |
| Interaction | NUFIP2 interactions | VWF KRTAP3-3 ESR2 CHD4 LCE1B LCE1F KRTAP10-7 KRTAP10-3 MEGF6 KRTAP3-2 CHRD KRTAP5-2 AGRN MEGF11 | 1.13e-07 | 417 | 115 | 14 | int:NUFIP2 |
| Interaction | KRTAP10-9 interactions | WNT11 LCE1C LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 CHRD KRTAP5-2 | 1.36e-07 | 241 | 115 | 11 | int:KRTAP10-9 |
| Interaction | CHIC2 interactions | 1.96e-07 | 73 | 115 | 7 | int:CHIC2 | |
| Interaction | LCE3A interactions | 2.59e-07 | 76 | 115 | 7 | int:LCE3A | |
| Interaction | KRTAP1-5 interactions | 3.06e-07 | 48 | 115 | 6 | int:KRTAP1-5 | |
| Interaction | RGS17 interactions | 3.06e-07 | 48 | 115 | 6 | int:RGS17 | |
| Interaction | VASN interactions | LCE1C LCE1B LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-6 KRTAP3-2 KRTAP3-1 | 3.43e-07 | 160 | 115 | 9 | int:VASN |
| Interaction | NID2 interactions | 6.07e-07 | 86 | 115 | 7 | int:NID2 | |
| Interaction | CATSPER1 interactions | 6.31e-07 | 126 | 115 | 8 | int:CATSPER1 | |
| Interaction | FBXO2 interactions | ATRN FRAS1 WNT10B LAMA1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 FBN2 JAG1 AGRN CTU1 | 6.50e-07 | 411 | 115 | 13 | int:FBXO2 |
| Interaction | KRTAP10-6 interactions | 7.11e-07 | 88 | 115 | 7 | int:KRTAP10-6 | |
| Interaction | FBLN1 interactions | 7.55e-07 | 129 | 115 | 8 | int:FBLN1 | |
| Interaction | NOTCH2 interactions | EPHB2 ZNF775 ESR2 WNT10B LAMB2 ZNF865 ZNF594 FBN2 MARCHF3 JAG1 ADAMTS15 DTX2 BMPER | 8.97e-07 | 423 | 115 | 13 | int:NOTCH2 |
| Interaction | KRTAP10-7 interactions | WNT11 LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 ZSCAN10 CHRD KRTAP5-2 | 9.48e-07 | 293 | 115 | 11 | int:KRTAP10-7 |
| Interaction | LCE3E interactions | 1.18e-06 | 60 | 115 | 6 | int:LCE3E | |
| Interaction | KRTAP2-3 interactions | 1.20e-06 | 95 | 115 | 7 | int:KRTAP2-3 | |
| Interaction | CLEC11A interactions | 1.28e-06 | 96 | 115 | 7 | int:CLEC11A | |
| Interaction | SPRY3 interactions | 1.57e-06 | 35 | 115 | 5 | int:SPRY3 | |
| Interaction | KRTAP2-4 interactions | 1.81e-06 | 101 | 115 | 7 | int:KRTAP2-4 | |
| Interaction | OIT3 interactions | 1.90e-06 | 65 | 115 | 6 | int:OIT3 | |
| Interaction | CRCT1 interactions | 2.08e-06 | 66 | 115 | 6 | int:CRCT1 | |
| Interaction | ZNF138 interactions | 3.65e-06 | 19 | 115 | 4 | int:ZNF138 | |
| Interaction | LCE3D interactions | 3.78e-06 | 73 | 115 | 6 | int:LCE3D | |
| Interaction | PLA2G10 interactions | 3.84e-06 | 113 | 115 | 7 | int:PLA2G10 | |
| Interaction | IGFL3 interactions | 4.42e-06 | 75 | 115 | 6 | int:IGFL3 | |
| Interaction | FUCA2 interactions | 4.49e-06 | 43 | 115 | 5 | int:FUCA2 | |
| Interaction | KRTAP1-1 interactions | 4.65e-06 | 219 | 115 | 9 | int:KRTAP1-1 | |
| Interaction | ALPP interactions | 6.75e-06 | 123 | 115 | 7 | int:ALPP | |
| Interaction | NID1 interactions | 7.80e-06 | 48 | 115 | 5 | int:NID1 | |
| Interaction | CFC1 interactions | 7.91e-06 | 126 | 115 | 7 | int:CFC1 | |
| Interaction | KANSL3 interactions | 9.82e-06 | 86 | 115 | 6 | int:KANSL3 | |
| Interaction | KRTAP5-8 interactions | 9.93e-06 | 8 | 115 | 3 | int:KRTAP5-8 | |
| Interaction | MFAP5 interactions | 1.16e-05 | 52 | 115 | 5 | int:MFAP5 | |
| Interaction | NOTCH2NLA interactions | ESR2 DGKQ LCE1B LCE1E LCE1A LCE3A LCE1F KRTAP10-7 KRTAP10-3 KRTAP3-1 CHRD | 1.17e-05 | 381 | 115 | 11 | int:NOTCH2NLA |
| Interaction | SLC39A7 interactions | 1.20e-05 | 187 | 115 | 8 | int:SLC39A7 | |
| Interaction | MUC4 interactions | 1.48e-05 | 9 | 115 | 3 | int:MUC4 | |
| Interaction | KRTAP10-10 interactions | 1.60e-05 | 27 | 115 | 4 | int:KRTAP10-10 | |
| Interaction | SDF2L1 interactions | 1.60e-05 | 322 | 115 | 10 | int:SDF2L1 | |
| Interaction | MANEA interactions | 2.36e-05 | 60 | 115 | 5 | int:MANEA | |
| Interaction | TOP3B interactions | SETD1A ERBB2 FRAS1 RAPGEF6 KMT2B CTC1 SREBF1 LAMB2 DGKQ LAMB3 IREB2 LAMC3 ZNF865 ADGRA2 BIRC6 KMT2C FBXO22 MEGF6 KCNQ2 DTX2 AGRN PCNT | 2.58e-05 | 1470 | 115 | 22 | int:TOP3B |
| Interaction | SPRY2 interactions | 2.68e-05 | 152 | 115 | 7 | int:SPRY2 | |
| Interaction | KRTAP4-1 interactions | 2.81e-05 | 31 | 115 | 4 | int:KRTAP4-1 | |
| Interaction | ZNF155 interactions | 2.89e-05 | 11 | 115 | 3 | int:ZNF155 | |
| Interaction | ADAMTSL4 interactions | 3.50e-05 | 217 | 115 | 8 | int:ADAMTSL4 | |
| Interaction | NECTIN2 interactions | 3.58e-05 | 159 | 115 | 7 | int:NECTIN2 | |
| Interaction | EDN3 interactions | 3.61e-05 | 108 | 115 | 6 | int:EDN3 | |
| Interaction | FBLN2 interactions | 3.75e-05 | 66 | 115 | 5 | int:FBLN2 | |
| Interaction | ATXN7 interactions | 3.80e-05 | 109 | 115 | 6 | int:ATXN7 | |
| Interaction | KRTAP6-3 interactions | 3.88e-05 | 161 | 115 | 7 | int:KRTAP6-3 | |
| Interaction | KRT83 interactions | 4.34e-05 | 68 | 115 | 5 | int:KRT83 | |
| Interaction | PCSK5 interactions | 4.43e-05 | 112 | 115 | 6 | int:PCSK5 | |
| Interaction | RGS20 interactions | 5.93e-05 | 118 | 115 | 6 | int:RGS20 | |
| Interaction | NCR3 interactions | 6.52e-05 | 120 | 115 | 6 | int:NCR3 | |
| Interaction | EFEMP1 interactions | 7.48e-05 | 123 | 115 | 6 | int:EFEMP1 | |
| Interaction | IL5RA interactions | 7.82e-05 | 124 | 115 | 6 | int:IL5RA | |
| Interaction | ADAMTSL3 interactions | 7.83e-05 | 15 | 115 | 3 | int:ADAMTSL3 | |
| Interaction | VWC2L interactions | 7.85e-05 | 40 | 115 | 4 | int:VWC2L | |
| Cytoband | 1q21.3 | 6.61e-07 | 117 | 119 | 6 | 1q21.3 | |
| Cytoband | 21q22.3 | 2.21e-05 | 128 | 119 | 5 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 DSCR9 KRTAP24-1 PCNT | 6.07e-05 | 377 | 119 | 7 | chr21q22 |
| Cytoband | 17q12-q21 | 7.97e-05 | 32 | 119 | 3 | 17q12-q21 | |
| Cytoband | 11p15.5 | 2.62e-04 | 118 | 119 | 4 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 6.73e-04 | 404 | 119 | 6 | chr1q21 | |
| Cytoband | 7q36.1 | 9.63e-04 | 74 | 119 | 3 | 7q36.1 | |
| Cytoband | 19q13.41 | 1.12e-03 | 78 | 119 | 3 | 19q13.41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.51e-03 | 473 | 119 | 6 | chr17q21 | |
| GeneFamily | Laminin subunits | 1.46e-16 | 12 | 91 | 8 | 626 | |
| GeneFamily | Keratin associated proteins | KRTAP3-3 KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 KRTAP5-2 | 1.78e-10 | 109 | 91 | 10 | 619 |
| GeneFamily | Late cornified envelope proteins | 2.43e-10 | 18 | 91 | 6 | 627 | |
| GeneFamily | Wnt family|Endogenous ligands | 1.13e-04 | 19 | 91 | 3 | 360 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 1.49e-04 | 4 | 91 | 2 | 1096 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.59e-04 | 34 | 91 | 3 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF775 ZNF843 ZNF613 SALL3 ZNF862 ZNF865 ZNF594 ZSCAN10 ZNF737 ZNF350 ZNF669 | 9.44e-04 | 718 | 91 | 11 | 28 |
| GeneFamily | PHD finger proteins | 1.10e-03 | 90 | 91 | 4 | 88 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.14e-03 | 41 | 91 | 3 | 1298 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.05e-03 | 19 | 91 | 2 | 50 | |
| GeneFamily | CD molecules|Mucins | 4.94e-03 | 21 | 91 | 2 | 648 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 8.10e-03 | 27 | 91 | 2 | 1253 | |
| Coexpression | NABA_MATRISOME | HGFAC LAMB4 FRAS1 RELN VWF CRIM1 SPOCK1 WNT10B WNT11 WNT9B LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 MUC5B ADAMTS5 TECTA ISM2 ZP3 SVEP1 SCUBE1 FBN2 MEGF6 IGFBP7 ACAN ADAMTS15 SCUBE3 CHRD BMPER FST MUC2 AGRN MEGF11 FBN3 MEGF10 | 6.62e-27 | 1026 | 118 | 40 | M5889 |
| Coexpression | NABA_MATRISOME | HGFAC FRAS1 RELN VWF CRIM1 SPOCK1 WNT10B WNT11 WNT9B LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 SEMA5A LAMC2 LAMC3 MUC5B ADAMTS5 TECTA ISM2 ZP3 SVEP1 EGFEM1P SCUBE1 FBN2 MEGF6 IGFBP7 ACAN ADAMTS15 SCUBE3 CHRD BMPER FST MUC2 AGRN MEGF11 MEGF10 | 4.47e-26 | 1008 | 118 | 39 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 FRAS1 RELN VWF CRIM1 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 TECTA ZP3 SVEP1 FBN2 IGFBP7 BMPER AGRN FBN3 | 3.80e-23 | 196 | 118 | 21 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | LAMB4 FRAS1 RELN VWF CRIM1 SPOCK1 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 TECTA ZP3 SVEP1 FBN2 IGFBP7 ACAN BMPER AGRN FBN3 | 8.60e-23 | 275 | 118 | 23 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 RELN VWF CRIM1 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 TECTA ZP3 SVEP1 EGFEM1P FBN2 IGFBP7 BMPER AGRN | 7.10e-22 | 191 | 118 | 20 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | FRAS1 RELN VWF CRIM1 SPOCK1 LAMA1 LAMA2 NTNG1 LAMB2 LAMB3 LAMC1 LAMC2 LAMC3 TECTA ZP3 SVEP1 EGFEM1P FBN2 IGFBP7 ACAN BMPER AGRN | 1.41e-21 | 270 | 118 | 22 | MM17057 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.75e-15 | 40 | 118 | 10 | M5887 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | KRTAP3-3 KRT85 LCE1C LCE1B LCE1E LCE1A MT1X KRTAP3-2 KRTAP3-1 KRTAP5-2 | 3.07e-08 | 204 | 118 | 10 | MM966 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | HGFAC WNT10B WNT11 WNT9B SEMA5A MUC5B ADAMTS5 ISM2 SCUBE1 MEGF6 ADAMTS15 SCUBE3 CHRD FST MUC2 MEGF11 MEGF10 | 3.61e-08 | 738 | 118 | 17 | MM17058 |
| Coexpression | NABA_SECRETED_FACTORS | HGFAC WNT10B WNT11 WNT9B ISM2 SCUBE1 MEGF6 SCUBE3 CHRD FST MEGF11 MEGF10 | 4.37e-08 | 338 | 118 | 12 | MM17064 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | HGFAC WNT10B WNT11 WNT9B SEMA5A MUC5B ADAMTS5 ISM2 SCUBE1 MEGF6 ADAMTS15 SCUBE3 CHRD FST MUC2 MEGF11 MEGF10 | 4.64e-08 | 751 | 118 | 17 | M5885 |
| Coexpression | NABA_SECRETED_FACTORS | HGFAC WNT10B WNT11 WNT9B ISM2 SCUBE1 MEGF6 SCUBE3 CHRD FST MEGF11 MEGF10 | 5.13e-08 | 343 | 118 | 12 | M5883 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 5.35e-08 | 23 | 118 | 5 | M48001 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ERBB2 RELN SALL3 WNT11 LAMA1 LAMC2 LAMC3 ADAMTS5 SVEP1 CARTPT SCUBE1 IGFBP7 JAG1 DLL3 ADAMTS15 SCUBE3 CHRD KCNQ2 FST MEGF11 | 6.74e-08 | 1074 | 118 | 20 | M1941 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN | 1.56e-06 | 179 | 118 | 8 | M8519 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.76e-06 | 6 | 118 | 3 | M48000 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.79e-06 | 20 | 118 | 4 | MM17053 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 2.76e-06 | 49 | 118 | 5 | MM452 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 3.62e-06 | 268 | 118 | 9 | M45796 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | RELN WNT10B LAMC3 ADGRA2 CARTPT SCUBE1 NRXN2 ACAN DLL3 KCNQ2 CACNA1G | 4.82e-06 | 438 | 118 | 11 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | RELN WNT10B LAMC3 ADGRA2 CARTPT SCUBE1 NRXN2 ACAN DLL3 KCNQ2 CACNA1G | 5.03e-06 | 440 | 118 | 11 | MM832 |
| Coexpression | BENPORATH_EED_TARGETS | TNFRSF25 RELN ERBB4 OLFML2B WNT10B WNT11 ADAMTS5 LHX6 MT1X FBN2 IGFBP7 DPF3 ADAMTS15 SCUBE3 CHRD CACNA1G MEGF11 | 5.36e-06 | 1059 | 118 | 17 | M7617 |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 6.23e-06 | 365 | 118 | 10 | M39018 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | CRIM1 OLFML2B LAMB2 LAMC1 SVEP1 ITGBL1 SCUBE1 IGFBP7 NRXN2 JAG1 CHRD BMPER FST MEGF10 | 9.41e-06 | 767 | 118 | 14 | M39209 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 1.43e-05 | 174 | 118 | 7 | M45676 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | ERBB4 OLFML2B WNT10B WNT11 ADAMTS5 ISM2 LHX6 ADGRA2 MT1X FBN2 DPF3 ACAN ADAMTS15 CHRD CACNA1G MEGF11 | 1.66e-05 | 1035 | 118 | 16 | M9898 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 2.98e-05 | 195 | 118 | 7 | M45684 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 6.34e-05 | 385 | 118 | 9 | M39264 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.34e-05 | 479 | 118 | 10 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.80e-05 | 483 | 118 | 10 | MM1082 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | RELN SPOCK1 WNT9B LAMC2 LAMC3 CARTPT SCUBE1 NRXN2 ACAN DLL3 KCNQ2 | 7.57e-05 | 591 | 118 | 11 | M2019 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | RELN SPOCK1 WNT9B LAMC2 LAMC3 CARTPT SCUBE1 NRXN2 ACAN DLL3 KCNQ2 | 8.78e-05 | 601 | 118 | 11 | MM866 |
| Coexpression | LIU_CMYB_TARGETS_UP | 1.01e-04 | 164 | 118 | 6 | M15066 | |
| Coexpression | CLIMENT_BREAST_CANCER_COPY_NUMBER_UP | 1.47e-04 | 23 | 118 | 3 | M13910 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.63e-04 | 179 | 118 | 6 | M39308 | |
| Coexpression | TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL | 1.67e-04 | 61 | 118 | 4 | M41672 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | GPR155 VWF CRIM1 LAMB2 LAMC1 LHX6 ADGRA2 TSPAN5 SCARF1 MT1X MEGF6 IGFBP7 JAG1 | 1.86e-04 | 888 | 118 | 13 | M39049 |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS | 2.14e-04 | 26 | 118 | 3 | M47999 | |
| Coexpression | GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP | 2.32e-04 | 191 | 118 | 6 | M4722 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 2.50e-04 | 124 | 118 | 5 | M45686 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | EPHB2 RELN SPOCK1 ADGRA2 TSPAN5 ITGBL1 FBN2 DPF3 SCUBE3 BMPER | 2.50e-04 | 567 | 118 | 10 | M2129 |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 2.52e-04 | 194 | 118 | 6 | M8864 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 2.59e-04 | 125 | 118 | 5 | M1320 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.97e-04 | 200 | 118 | 6 | M5930 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN | 2.97e-04 | 200 | 118 | 6 | M4793 | |
| Coexpression | FAN_EMBRYONIC_CTX_IN_3_INTERNEURON | 2.98e-04 | 6 | 118 | 2 | M39029 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.98e-04 | 29 | 118 | 3 | MM17055 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | 3.38e-04 | 589 | 118 | 10 | M45662 | |
| Coexpression | LI_PROSTATE_CANCER_EPIGENETIC | 4.01e-04 | 32 | 118 | 3 | M10861 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 4.54e-04 | 303 | 118 | 7 | M39040 | |
| Coexpression | KRAS.AMP.LUNG_UP.V1_DN | 4.66e-04 | 142 | 118 | 5 | M2859 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 4.76e-04 | 505 | 118 | 9 | M39167 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | FRAS1 ERBB4 CRIM1 LAMA1 LAMC1 LAMC2 FBN2 JAG1 SCUBE3 CACNA1G BMPER | 1.66e-09 | 175 | 109 | 11 | gudmap_kidney_P4_CapMesRenVes_Crym_200 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | FRAS1 ERBB4 CRIM1 LAMA1 LAMC1 SEMA5A LAMC2 FBN2 IGFBP7 JAG1 SCUBE3 CACNA1G BMPER AGRN | 1.68e-08 | 398 | 109 | 14 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 3.01e-08 | 62 | 109 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.82e-07 | 165 | 109 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | ERBB4 OLFML2B LAMA1 LAMA2 NTNG1 SEMA5A ADAMTS5 TSPAN5 SVEP1 SCUBE1 FBN2 IGFBP7 DPF3 ATRNL1 JAG1 ANKMY2 CACNA1G | 4.13e-07 | 773 | 109 | 17 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.46e-07 | 195 | 109 | 9 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | GPR155 FRAS1 ERBB4 CRIM1 LAMA1 LAMC1 SEMA5A LAMC2 FBN2 IGFBP7 JAG1 SCUBE3 CACNA1G KRTAP5-2 BMPER AGRN | 2.44e-06 | 783 | 109 | 16 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | RELN POTEF WNT10B WNT11 LAMA1 SEMA5A SVEP1 CARTPT SCUBE1 NRXN2 ATRNL1 DLL3 SCUBE3 KCNQ2 CACNA1G FBN3 MEGF10 | 1.10e-05 | 986 | 109 | 17 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | GPR155 RELN ERBB4 CRIM1 OLFML2B LAMA1 NTNG1 LAMB2 LAMC1 SEMA5A LAMC2 IGFBP7 ACAN JAG1 SCUBE3 AGRN | 1.51e-05 | 905 | 109 | 16 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | OLFML2B LAMA2 LAMB2 LAMC1 ADAMTS5 SVEP1 ITGBL1 IGFBP7 ADAMTS15 BMPER FST | 1.55e-05 | 437 | 109 | 11 | GSM777046_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.61e-05 | 156 | 109 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.05e-05 | 293 | 109 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.10e-05 | 65 | 109 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | CRIM1 OLFML2B LAMA2 LAMB2 LAMC1 SEMA5A ADAMTS5 SVEP1 IGFBP7 JAG1 FST | 2.17e-05 | 453 | 109 | 11 | GSM777067_500 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 4.08e-05 | 320 | 109 | 9 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | RELN ERBB4 VWF SALL3 LAMA1 SEMA5A ZSCAN10 KCNQ2 BMPER FBN3 MEGF10 | 4.35e-05 | 489 | 109 | 11 | PCBC_MESO-5_fibroblast_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.55e-05 | 125 | 109 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | EPHB2 SPOCK1 NTNG1 LAMB3 LAMC1 SEMA5A ADAMTS5 ADGRA2 BIRC6 ATP2C2 ADAMTS15 AGRN MEGF11 MEGF10 | 6.53e-05 | 806 | 109 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | RAPGEF6 CRIM1 SPOCK1 LAMC1 SEMA5A ADAMTS5 ADGRA2 SVEP1 ITGBL1 MEGF6 IGFBP7 KRTAP3-1 SCUBE3 BMPER | 7.25e-05 | 814 | 109 | 14 | JC_fibro_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | MICAL1 VWF WNT11 LAMA2 NTNG1 SEMA5A LHX6 ADGRA2 SVEP1 FBN2 DPF3 ATRNL1 MARCHF3 ADAMTS15 ANKMY2 CACNA1G BMPER | 7.49e-05 | 1148 | 109 | 17 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | placenta | 7.95e-05 | 349 | 109 | 9 | placenta | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 9.25e-05 | 356 | 109 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | OLFML2B LAMA1 LAMA2 NTNG1 ADAMTS5 SVEP1 SCUBE1 IGFBP7 CACNA1G | 1.03e-04 | 361 | 109 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 1.24e-04 | 370 | 109 | 9 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | OLFML2B WNT11 LAMA2 LAMB2 LAMC1 SEMA5A ADAMTS5 SVEP1 IGFBP7 ATRNL1 | 1.44e-04 | 466 | 109 | 10 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | ERBB4 LAMA1 LAMA2 SEMA5A ADAMTS5 TSPAN5 SVEP1 SCUBE1 FBN2 IGFBP7 ATRNL1 JAG1 CACNA1G | 1.56e-04 | 768 | 109 | 13 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | MICAL1 RAPGEF6 LAMA2 NTNG1 SEMA5A ADGRA2 ITGBL1 FBN2 ATRNL1 BMPER FST AGRN MEGF10 | 1.65e-04 | 772 | 109 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | RELN SALL3 WNT10B WNT11 LAMA1 SVEP1 CARTPT SCUBE1 ATRNL1 DLL3 SCUBE3 KCNQ2 CACNA1G FBN3 MEGF10 | 1.69e-04 | 994 | 109 | 15 | PCBC_EB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FRAS1 OLFML2B LAMA1 LAMA2 NTNG1 ADAMTS5 SVEP1 SCUBE1 FBN2 IGFBP7 ATRNL1 JAG1 CACNA1G | 1.75e-04 | 777 | 109 | 13 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 2.17e-04 | 166 | 109 | 6 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_top-relative-expression-ranked_500 | 2.20e-04 | 491 | 109 | 10 | PCBC_MESO-5_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.06e-04 | 114 | 109 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.50e-04 | 337 | 109 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | OLFML2B LAMA1 SEMA5A SVEP1 CARTPT ITGBL1 SCUBE1 IGFBP7 ACAN ATRNL1 SCUBE3 CACNA1G BMPER FBN3 | 3.63e-04 | 951 | 109 | 14 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 4.18e-04 | 122 | 109 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | GPR155 CRIM1 LAMC1 SEMA5A LAMC2 FBN2 JAG1 SCUBE3 CACNA1G KRTAP5-2 BMPER DISP1 | 4.66e-04 | 749 | 109 | 12 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | RELN CRIM1 SPOCK1 LAMA1 LAMB3 LAMC1 SEMA5A SVEP1 ITGBL1 IGFBP7 ACAN SCUBE3 BMPER FST | 4.66e-04 | 975 | 109 | 14 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | HGFAC ERBB4 CRIM1 WNT10B NTNG1 SEMA5A ADAMTS5 ADGRA2 SVEP1 CARTPT SCUBE1 FBN2 ADAMTS15 SCUBE3 BMPER | 4.69e-04 | 1094 | 109 | 15 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.82e-04 | 445 | 109 | 9 | GSM777043_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.03e-04 | 127 | 109 | 5 | gudmap_kidney_adult_Mesangium_Meis_k1_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 5.23e-04 | 450 | 109 | 9 | GSM777063_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | RELN SALL3 WNT10B LAMA1 SVEP1 CARTPT SCUBE1 ACAN ATRNL1 SCUBE3 KCNQ2 CACNA1G FBN3 MEGF10 | 5.53e-04 | 992 | 109 | 14 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | GPR155 OLFML2B WNT11 LAMA2 NTNG1 SEMA5A LHX6 ADGRA2 IGFBP7 DPF3 ATRNL1 DLL3 CACNA1G | 5.65e-04 | 878 | 109 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 7.03e-04 | 207 | 109 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ERBB4 OLFML2B LAMA1 LAMA2 NTNG1 SEMA5A ADAMTS5 TSPAN5 SVEP1 SCUBE1 IGFBP7 CACNA1G | 7.70e-04 | 793 | 109 | 12 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | EPHB2 RELN ERBB4 VWF SPOCK1 LAMA1 SEMA5A FBN2 MEGF6 ZNF737 ANKMY2 BMPER FST AGRN FBN3 | 8.05e-04 | 1153 | 109 | 15 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | WNT11 WNT9B LAMA1 LAMC1 SEMA5A LAMC2 CHD4 LCE1C BIRC6 JAG1 SCUBE3 AGRN | 8.40e-04 | 801 | 109 | 12 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 9.45e-04 | 146 | 109 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_500 | 9.74e-04 | 394 | 109 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 1.00e-03 | 148 | 109 | 5 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | SPOCK1 NTNG1 LAMC1 SEMA5A BIRC6 CARTPT FBN2 NRXN2 KCNQ2 BMPER AGRN MEGF10 | 1.01e-03 | 818 | 109 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 1.06e-03 | 497 | 109 | 9 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 1.07e-03 | 498 | 109 | 9 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.10e-03 | 151 | 109 | 5 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.11e-03 | 310 | 109 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | ATRN OLFML2B LAMA2 NTNG1 SEMA5A LHX6 ADGRA2 MEGF6 ATRNL1 CACNA1G | 1.14e-03 | 607 | 109 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | 1.18e-03 | 406 | 109 | 8 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP3-3 KRT85 KRTAP5-5 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-3 KRTAP3-2 KRTAP3-1 KRTAP24-1 | 7.46e-12 | 146 | 119 | 10 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | OLFML2B WNT11 SEMA5A LAMC3 ADAMTS5 SCUBE1 MT1X IGFBP7 ATRNL1 JAG1 | 1.18e-10 | 193 | 119 | 10 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-09 | 192 | 119 | 9 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.75e-09 | 194 | 119 | 9 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-09 | 197 | 119 | 9 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-08 | 162 | 119 | 8 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-08 | 172 | 119 | 8 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-08 | 182 | 119 | 8 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-08 | 182 | 119 | 8 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.05e-08 | 187 | 119 | 8 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.59e-08 | 190 | 119 | 8 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-08 | 191 | 119 | 8 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-08 | 191 | 119 | 8 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-08 | 193 | 119 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.18e-08 | 193 | 119 | 8 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-08 | 193 | 119 | 8 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-08 | 194 | 119 | 8 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-08 | 194 | 119 | 8 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-08 | 194 | 119 | 8 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.83e-08 | 196 | 119 | 8 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.83e-08 | 196 | 119 | 8 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.83e-08 | 196 | 119 | 8 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.06e-08 | 197 | 119 | 8 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.06e-08 | 197 | 119 | 8 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.06e-08 | 197 | 119 | 8 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.06e-08 | 197 | 119 | 8 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.06e-08 | 197 | 119 | 8 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | distal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.31e-08 | 198 | 119 | 8 | 37ce7b485ffb207e75afd1b576b486c6d59fc136 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.31e-08 | 198 | 119 | 8 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-08 | 199 | 119 | 8 | 4032f03a4165f5f2a90ef1d8315cc743ce9075bb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.81e-08 | 200 | 119 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.81e-08 | 200 | 119 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | distal-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.81e-08 | 200 | 119 | 8 | 65a50f03b0027ccefb51b8f77afa283d4a3b3567 | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.81e-08 | 200 | 119 | 8 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.81e-08 | 200 | 119 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.81e-08 | 200 | 119 | 8 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.81e-08 | 200 | 119 | 8 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.81e-08 | 200 | 119 | 8 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 6.81e-08 | 200 | 119 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.81e-08 | 200 | 119 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.81e-08 | 200 | 119 | 8 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.81e-08 | 200 | 119 | 8 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.81e-08 | 200 | 119 | 8 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-07 | 160 | 119 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-07 | 160 | 119 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-07 | 170 | 119 | 7 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-07 | 172 | 119 | 7 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.64e-07 | 175 | 119 | 7 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.82e-07 | 176 | 119 | 7 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.20e-07 | 178 | 119 | 7 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.61e-07 | 180 | 119 | 7 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.61e-07 | 180 | 119 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.82e-07 | 181 | 119 | 7 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.82e-07 | 181 | 119 | 7 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-07 | 182 | 119 | 7 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.04e-07 | 182 | 119 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-07 | 182 | 119 | 7 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.26e-07 | 183 | 119 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 6.50e-07 | 184 | 119 | 7 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.74e-07 | 185 | 119 | 7 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-07 | 185 | 119 | 7 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-07 | 185 | 119 | 7 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.99e-07 | 186 | 119 | 7 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.99e-07 | 186 | 119 | 7 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.99e-07 | 186 | 119 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-07 | 188 | 119 | 7 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 7.51e-07 | 188 | 119 | 7 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.51e-07 | 188 | 119 | 7 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-07 | 188 | 119 | 7 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-07 | 188 | 119 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.78e-07 | 189 | 119 | 7 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.78e-07 | 189 | 119 | 7 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.78e-07 | 189 | 119 | 7 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-07 | 189 | 119 | 7 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-07 | 189 | 119 | 7 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.06e-07 | 190 | 119 | 7 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-07 | 190 | 119 | 7 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-07 | 190 | 119 | 7 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.06e-07 | 190 | 119 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-07 | 190 | 119 | 7 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.06e-07 | 190 | 119 | 7 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.06e-07 | 190 | 119 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.06e-07 | 190 | 119 | 7 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.06e-07 | 190 | 119 | 7 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.20e-07 | 119 | 119 | 6 | 6425425b2e622c97b6c74c530ccbfe394d3b202d | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 8.35e-07 | 191 | 119 | 7 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.35e-07 | 191 | 119 | 7 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.35e-07 | 191 | 119 | 7 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.35e-07 | 191 | 119 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-07 | 192 | 119 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-07 | 192 | 119 | 7 | c3707243c5590d852c9f28429c96f50a1fa6b0dc | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-07 | 192 | 119 | 7 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.64e-07 | 192 | 119 | 7 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-07 | 192 | 119 | 7 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-07 | 192 | 119 | 7 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-07 | 192 | 119 | 7 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-07 | 192 | 119 | 7 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.64e-07 | 192 | 119 | 7 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.64e-07 | 192 | 119 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-07 | 192 | 119 | 7 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| Computational | Adhesion molecules. | 3.39e-08 | 141 | 55 | 9 | MODULE_122 | |
| Computational | Developmental processes. | 6.02e-06 | 333 | 55 | 10 | MODULE_220 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-04 | 50 | 55 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Drug | AC1L1G72 | 2.89e-14 | 11 | 119 | 7 | CID000003553 | |
| Drug | AC1L1B58 | 1.26e-10 | 29 | 119 | 7 | CID000001288 | |
| Drug | kalinin | 4.35e-10 | 55 | 119 | 8 | CID000032518 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 5.09e-10 | 83 | 119 | 9 | CID011968896 | |
| Drug | LG 5 | 8.95e-10 | 60 | 119 | 8 | CID011840957 | |
| Drug | Calcort | 9.84e-10 | 38 | 119 | 7 | CID000026709 | |
| Drug | dysprosium | 4.96e-09 | 74 | 119 | 8 | CID000023912 | |
| Drug | 2-amino-5-methylpyridine | 6.84e-09 | 77 | 119 | 8 | CID000015348 | |
| Drug | LMWH | LAMB4 ERBB4 VWF SPOCK1 ESR2 LAMA1 LAMA2 LAMB2 LAMC1 LAMC2 LAMC3 ISM2 SCARF1 IGFBP7 ACAN KCNQ2 FST AGRN | 1.07e-08 | 663 | 119 | 18 | CID000000772 |
| Drug | CC270 | 2.43e-08 | 59 | 119 | 7 | CID006918852 | |
| Drug | YIGSR | 1.89e-07 | 79 | 119 | 7 | CID000123977 | |
| Drug | NSC 714187 | 3.14e-07 | 85 | 119 | 7 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 3.41e-07 | 86 | 119 | 7 | CID000001322 | |
| Drug | H-9 dihydrochloride | 4.66e-07 | 90 | 119 | 7 | CID000003544 | |
| Drug | AC1O0B8G | 1.21e-06 | 262 | 119 | 10 | CID000091605 | |
| Drug | butylparaben | 1.75e-06 | 157 | 119 | 8 | ctd:C038091 | |
| Drug | Rgd Peptide | 4.73e-06 | 239 | 119 | 9 | CID000104802 | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | TNFRSF25 LAMB4 ERBB4 ESR2 LAMA1 LAMA2 LAMB2 LAMC1 LAMC2 LAMC3 CAMTA2 TSPAN5 SCARF1 MARCHF3 ATP2C2 ANKMY2 PCNT | 5.10e-06 | 909 | 119 | 17 | CID000002524 |
| Drug | enzacamene | 5.27e-06 | 129 | 119 | 7 | ctd:C038939 | |
| Drug | Sikvav | 6.95e-06 | 24 | 119 | 4 | CID005487517 | |
| Drug | octylmethoxycinnamate | 8.61e-06 | 139 | 119 | 7 | ctd:C118580 | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.01e-05 | 199 | 119 | 8 | 6105_UP | |
| Drug | Bretylium tosylate [61-75-6]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.05e-05 | 200 | 119 | 8 | 3057_UP | |
| Drug | I-Q-S | 1.83e-05 | 156 | 119 | 7 | CID000003540 | |
| Drug | BM165 | 2.23e-05 | 11 | 119 | 3 | CID003352881 | |
| Drug | Gdrgdsp | 2.35e-05 | 109 | 119 | 6 | CID000115346 | |
| Drug | DB04780 | 3.17e-05 | 170 | 119 | 7 | CID005459389 | |
| Drug | Te-6 | 3.28e-05 | 35 | 119 | 4 | CID000198470 | |
| Drug | taxol | LAMB4 ERBB2 ERBB4 LAMA1 LAMA2 LAMB2 LAMC1 LAMC2 LAMC3 BIRC6 CARTPT PCNT | 3.79e-05 | 560 | 119 | 12 | CID000004666 |
| Drug | cobalt-60 | LAMB4 LAMA1 LAMA2 LAMB2 IREB2 LAMC1 LAMC2 LAMC3 CACNA1G AGRN | 3.93e-05 | 390 | 119 | 10 | CID000061492 |
| Drug | sulfate | HGFAC LAMB4 ERBB2 ERBB4 VWF SPOCK1 ESR2 LAMA1 LAMA2 LAMB2 LAMC1 LAMC2 LAMC3 ISM2 ZP3 SCARF1 ACAN FST AGRN | 4.02e-05 | 1292 | 119 | 19 | CID000001117 |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 4.13e-05 | 314 | 119 | 9 | CID000003542 | |
| Drug | Ikvav | 4.56e-05 | 38 | 119 | 4 | CID000131343 | |
| Drug | quercetin | LAMB4 ERBB2 ESR2 LAMA1 LAMA2 LAMB2 LAMC1 LAMC2 LAMC3 MT1X ATP2C2 | 4.61e-05 | 482 | 119 | 11 | CID005280343 |
| Drug | A0395 | 4.62e-05 | 75 | 119 | 5 | CID009906466 | |
| Drug | Androgen Antagonists | 4.62e-05 | 75 | 119 | 5 | ctd:D000726 | |
| Drug | chondroitin sulfate | 6.35e-05 | 413 | 119 | 10 | CID000024766 | |
| Drug | manganese | LAMB4 ERBB2 ERBB4 VWF LAMA1 LAMA2 LAMB2 IREB2 LAMC1 LAMC2 LAMC3 ATP2C2 CACNA1G AGRN | 6.73e-05 | 791 | 119 | 14 | CID000023930 |
| Drug | Grgds | 7.52e-05 | 83 | 119 | 5 | CID000123811 | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 2875_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 4361_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 6832_UP | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 3540_UP | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 1697_DN | |
| Drug | pyrido[3,4-d]pyrimidine | 8.10e-05 | 3 | 119 | 2 | CID014758064 | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; PC3; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 6290_UP | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 3337_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 6036_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 4523_DN | |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 4177_UP | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; HL60; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 2931_UP | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 5485_UP | |
| Drug | betulin | 8.97e-05 | 17 | 119 | 3 | CID000072326 | |
| Drug | BMS-186282 | 1.43e-04 | 95 | 119 | 5 | CID000002416 | |
| Drug | AC1L1EPA | 1.61e-04 | 4 | 119 | 2 | CID000028140 | |
| Drug | EGFR/ErbB2 inhibitor | 1.61e-04 | 4 | 119 | 2 | CID009843206 | |
| Drug | ALT-711 | 1.73e-04 | 21 | 119 | 3 | CID000216304 | |
| Drug | MRK 003 | EPHB2 ERBB2 SEMA5A MS4A4A IGFBP7 ATP2C2 DLL3 SCUBE3 KCNQ2 DTX2 BMPER MEGF11 MEGF10 | 1.74e-04 | 760 | 119 | 13 | ctd:C523799 |
| Drug | 2,4-diaminopyrimidine | 1.83e-04 | 54 | 119 | 4 | CID000067431 | |
| Drug | phenothrin | 1.99e-04 | 22 | 119 | 3 | CID000004767 | |
| Disease | Schizophrenia | SETD1A RELN ERBB4 RAPGEF6 ESR2 LAMA1 SREBF1 LAMA2 NTNG1 CHD4 LHX6 NRXN2 JAG1 KCNQ2 MEGF10 PCNT | 2.08e-07 | 883 | 111 | 16 | C0036341 |
| Disease | laminin subunit gamma-2 measurement | 1.40e-05 | 2 | 111 | 2 | EFO_0801756 | |
| Disease | caffeine measurement | 2.28e-05 | 15 | 111 | 3 | EFO_0021177 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.53e-05 | 49 | 111 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Autosomal dominant epilepsy with auditory features | 4.20e-05 | 3 | 111 | 2 | cv:C1838062 | |
| Disease | Junctional epidermolysis bullosa | 4.20e-05 | 3 | 111 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 4.20e-05 | 3 | 111 | 2 | cv:C0079683 | |
| Disease | EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 | 4.20e-05 | 3 | 111 | 2 | 600512 | |
| Disease | junctional epidermolysis bullosa Herlitz type (implicated_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:0060737 (implicated_via_orthology) | |
| Disease | Epilepsy, Familial Temporal Lobe 1 | 4.20e-05 | 3 | 111 | 2 | C4551957 | |
| Disease | Epilepsy, familial temporal lobe, 1 | 4.20e-05 | 3 | 111 | 2 | cv:C4551957 | |
| Disease | connective tissue disease (implicated_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 4.20e-05 | 3 | 111 | 2 | 226700 | |
| Disease | Herlitz Disease | 8.37e-05 | 4 | 111 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 8.37e-05 | 4 | 111 | 2 | C0079297 | |
| Disease | executive function measurement, cognitive function measurement | 8.37e-05 | 4 | 111 | 2 | EFO_0008354, EFO_0009332 | |
| Disease | stomach carcinoma (is_marker_for) | 9.90e-05 | 24 | 111 | 3 | DOID:5517 (is_marker_for) | |
| Disease | Brain Diseases | 1.12e-04 | 25 | 111 | 3 | C0006111 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 1.39e-04 | 5 | 111 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 1.39e-04 | 5 | 111 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 1.39e-04 | 5 | 111 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Encephalopathies | 1.42e-04 | 27 | 111 | 3 | C0085584 | |
| Disease | Developmental Disabilities | 1.95e-04 | 30 | 111 | 3 | C0008073 | |
| Disease | Junctional Epidermolysis Bullosa | 2.08e-04 | 6 | 111 | 2 | C0079301 | |
| Disease | cortical thickness | RELN KMT2B CRIM1 LAMA1 SREBF1 LAMA2 LAMC1 LAMC3 ADGRA2 SCUBE1 FBN2 JAG1 CTU1 | 2.86e-04 | 1113 | 111 | 13 | EFO_0004840 |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 2.91e-04 | 7 | 111 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 3.87e-04 | 8 | 111 | 2 | DOID:5520 (is_marker_for) | |
| Disease | S-warfarin to R-warfarin ratio measurement | 4.64e-04 | 95 | 111 | 4 | EFO_0803331 | |
| Disease | Malignant neoplasm of prostate | 5.43e-04 | 616 | 111 | 9 | C0376358 | |
| Disease | octadecanedioate measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0021056 | |
| Disease | Malignant neoplasm of breast | MICAL1 ERBB2 ERBB4 VWF ESR2 WNT10B LAMA2 TECTA IGFBP7 JAG1 FST CTU1 | 7.32e-04 | 1074 | 111 | 12 | C0006142 |
| Disease | gallbladder neoplasm | 7.54e-04 | 11 | 111 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 7.54e-04 | 11 | 111 | 2 | C0153452 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 7.54e-04 | 11 | 111 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | retinal drusen | 9.46e-04 | 51 | 111 | 3 | EFO_1001155 | |
| Disease | Carcinoma, Granular Cell | 9.82e-04 | 116 | 111 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 9.82e-04 | 116 | 111 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 9.82e-04 | 116 | 111 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 9.82e-04 | 116 | 111 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 9.82e-04 | 116 | 111 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 9.82e-04 | 116 | 111 | 4 | C0001418 | |
| Disease | Breast Carcinoma | 9.92e-04 | 538 | 111 | 8 | C0678222 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.18e-03 | 55 | 111 | 3 | EFO_0004623, HP_0002140 | |
| Disease | median neuropathy (biomarker_via_orthology) | 1.24e-03 | 14 | 111 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.36e-03 | 702 | 111 | 9 | C0009402 | |
| Disease | Parkinson disease | 1.38e-03 | 321 | 111 | 6 | MONDO_0005180 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.41e-03 | 128 | 111 | 4 | DOID:4450 (is_marker_for) | |
| Disease | glycerate measurement | 1.43e-03 | 15 | 111 | 2 | EFO_0021029 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.54e-03 | 447 | 111 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | triiodothyronine measurement | 1.63e-03 | 16 | 111 | 2 | EFO_0008392 | |
| Disease | cortical surface area measurement | RELN SREBF1 LAMA2 LAMC1 SEMA5A LAMC3 ADGRA2 SVEP1 SCUBE1 FBN2 MEGF6 JAG1 FBN3 | 1.64e-03 | 1345 | 111 | 13 | EFO_0010736 |
| Disease | carcinoma (implicated_via_orthology) | 1.83e-03 | 64 | 111 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Moyamoya Disease | 1.84e-03 | 17 | 111 | 2 | C0026654 | |
| Disease | venous thromboembolism, fibrinogen measurement | 2.08e-03 | 67 | 111 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | Hypertriglyceridemia | 2.30e-03 | 19 | 111 | 2 | EFO_0004211 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 2.30e-03 | 19 | 111 | 2 | DOID:2876 (is_marker_for) | |
| Disease | bipolar disorder (is_marker_for) | 2.30e-03 | 19 | 111 | 2 | DOID:3312 (is_marker_for) | |
| Disease | Prostatic Neoplasms | 2.32e-03 | 616 | 111 | 8 | C0033578 | |
| Disease | diabetic nephropathy | 2.52e-03 | 150 | 111 | 4 | EFO_0000401 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.64e-03 | 152 | 111 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | osteoarthritis (biomarker_via_orthology) | 2.81e-03 | 21 | 111 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 2.90e-03 | 156 | 111 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.90e-03 | 156 | 111 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.90e-03 | 156 | 111 | 4 | C2585653 | |
| Disease | interleukin 18 measurement | 2.98e-03 | 76 | 111 | 3 | EFO_0004581 | |
| Disease | Down syndrome (is_marker_for) | 3.08e-03 | 22 | 111 | 2 | DOID:14250 (is_marker_for) | |
| Disease | Liver carcinoma | 3.11e-03 | 507 | 111 | 7 | C2239176 | |
| Disease | Autistic Disorder | 3.12e-03 | 261 | 111 | 5 | C0004352 | |
| Disease | Atrial Fibrillation | 3.18e-03 | 160 | 111 | 4 | C0004238 | |
| Disease | Myasthenic Syndromes, Congenital | 3.67e-03 | 24 | 111 | 2 | C0751882 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.67e-03 | 24 | 111 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.67e-03 | 24 | 111 | 2 | C3805278 | |
| Disease | Mammary Carcinoma, Human | 3.76e-03 | 525 | 111 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.76e-03 | 525 | 111 | 7 | C1257931 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRTVCAGGCARCKGP | 216 | P04626 | |
| CTDICPKACDGIGTG | 326 | Q15303 | |
| CSGTDRLCACTKGGE | 946 | Q9NR09 | |
| CTSICRQGKCTRLGS | 1046 | Q2NKJ3 | |
| GCPLSIRSCKCSGER | 36 | Q96PE1 | |
| SVCVRGKCVRTGCDG | 696 | Q9UNA0 | |
| GRASCVCKKSPCPSV | 191 | O00468 | |
| IVTDGRSGCTPCSCD | 836 | O00468 | |
| GKGCSPIFCSISSDR | 156 | O94983 | |
| LPSGARCEVCRKTCG | 191 | P52824 | |
| GGSCSETPRSFECTC | 286 | Q9NYJ7 | |
| ECALSPPTCGSASCR | 2571 | Q75N90 | |
| CRSTGSLLKTCCDPE | 1396 | Q96F81 | |
| GCCSVLCSDKTGTLT | 371 | O75185 | |
| CSPDSTSVCVQGKCI | 641 | Q8TE58 | |
| DVSSCRGSLRKTGCC | 5636 | Q9HC84 | |
| LPCRGQTTCRGSCDS | 166 | P48200 | |
| VAPRCSACGCSKLHG | 356 | O75808 | |
| CDSVTGKCTCAPGFK | 421 | Q96KG7 | |
| CCGECRGSSVDPRST | 6 | Q8NEZ5 | |
| CFPCCRESGKSNVGT | 31 | A5A3E0 | |
| GTCSPVDGSCTCKEG | 456 | A6BM72 | |
| DSCGPSSPRCLTCTE | 566 | Q86XX4 | |
| ECTVCEACGKATDPG | 1006 | Q8NEZ4 | |
| RGCKSSITGSECSPA | 501 | Q92731 | |
| CSAVAPKTGNRCCIS | 21 | P78386 | |
| LVSCADCGRSGHPTC | 281 | Q92784 | |
| CSCHQCLSGSRTGPV | 196 | Q86UW9 | |
| RCGAKTSAGTFCGCD | 771 | Q7Z3F1 | |
| TPCALRTACGDCTSG | 931 | O75882 | |
| ICKSCGSGRGACTRC | 361 | P29323 | |
| GCTATETRTCDLPSC | 356 | Q6H9L7 | |
| CGCCPGRSSQKVSLK | 426 | O43526 | |
| SFDKSCRCGVCLPST | 21 | Q9BYR8 | |
| RCPGGDTCVCSTVAE | 256 | Q02817 | |
| RGCDGPSTTCTEESC | 1091 | Q9P2S2 | |
| SLCEKTSGQCLCRTG | 841 | P55268 | |
| SSDKSCRCGVCLPST | 21 | Q9BYR7 | |
| SSDKSCRCGVCLPST | 21 | Q9BYR6 | |
| SGCKATTRCLEGTAP | 6 | Q9UPM6 | |
| ACTSTKCLVVGAGPC | 81 | Q8TDZ2 | |
| PGSCDSLSGSCLICK | 876 | P24043 | |
| CTCRPGATGRKCDGC | 1546 | P24043 | |
| KPGATVGCCLSSCLS | 1646 | Q9UMN6 | |
| KTCRDVFCPGSSTCV | 166 | P19883 | |
| CVCKSRYPVCGSDGT | 111 | Q16270 | |
| SCSPVGSCACAGSCK | 6 | P80297 | |
| CSCPRAFTGKDCGTE | 186 | Q04756 | |
| SALCGGGDICKSTSC | 61 | O95613 | |
| RSCAEEPCGAGTCKE | 2281 | P16112 | |
| GPSCLKFCSGRGQCT | 671 | P78509 | |
| PEGSKCTKCSCTGGR | 181 | Q8N8U9 | |
| TGACQSSCKISSPCL | 641 | O43497 | |
| TSICCRPESALACGG | 116 | P59020 | |
| GSGRSRSCCTFCGVL | 136 | Q7Z7A3 | |
| GCTCRGEPRPSSCSE | 386 | Q5T3F8 | |
| GCLICKCREASASAG | 586 | Q9NZV1 | |
| TTCGEKGASKRCSVC | 321 | Q8IV38 | |
| KPCERTGSCFSGRCV | 61 | Q5VV63 | |
| SLSAFGCKVLCCTPG | 201 | Q96JQ5 | |
| PCECTGTLGTIHRSC | 86 | Q86UD3 | |
| TEGPGCDKASGRCLC | 541 | Q13751 | |
| KPLVVGRCCDRCSTG | 791 | A4D0S4 | |
| KPICCVPVCSGASSS | 121 | P60369 | |
| GSRVCLPGSCDSCSD | 16 | P60371 | |
| GSRVCLPGSCDSCSD | 16 | P60409 | |
| PACSCTSCGSCGGSK | 71 | Q701N4 | |
| KCPPVSSCCSVSSGG | 36 | Q5T7P2 | |
| KCPPVSSCCSVSSGG | 36 | Q5T7P3 | |
| SCGGSKRGCVSCGVS | 91 | Q701N2 | |
| KCPPVSSCCSVSSGG | 36 | Q5T751 | |
| KCPPVSSCCSVSSGG | 36 | Q5T753 | |
| KCPPVSSCCSVSSGG | 36 | Q5T754 | |
| GSRVCLPGSCDSCSD | 11 | P60413 | |
| SGGCGPSSERSCCLS | 36 | Q5TA76 | |
| VCTNCPTGTTGKRCE | 791 | P11047 | |
| CDNSGRCSCKPGVTG | 96 | Q13753 | |
| CKSPSCEPKTCSTTG | 71 | Q3LI83 | |
| IGKLCDCPRGTSCNS | 96 | Q16568 | |
| EIGVGVSRSSCCCSL | 1596 | P35556 | |
| KDGGELLCCDTCPSS | 456 | Q14839 | |
| EGKSECSCPAGCRVI | 36 | Q0D2K5 | |
| CKDTATGVRCSCPVG | 256 | Q8IWY4 | |
| CSKAGGVESCFLSCP | 421 | Q8IWY4 | |
| CNRSGKKDTCALTCP | 416 | Q8IX30 | |
| STVCGVCGKPFACKS | 976 | Q9BXA9 | |
| CTSPDGKICSNRGTC | 231 | O95965 | |
| CKETSLGFECECSPG | 351 | P78504 | |
| ACDSVSGECGKRCPA | 706 | O75095 | |
| RCNGSGFCECKTGTT | 431 | Q9Y2I2 | |
| TGSSKSFCSCVPCEG | 36 | Q96A25 | |
| SCSRTCGQCKGSLER | 1416 | Q8TEU7 | |
| KVTGSASDCALCACP | 1441 | P25391 | |
| GSSCKCACVAPPSAL | 111 | Q68BL8 | |
| SCKCQPGFSGKRCET | 1406 | Q4LDE5 | |
| NKIPCLCGTESCRGS | 1691 | O15047 | |
| VRGRCSAASGECTCP | 226 | Q14162 | |
| GSCLCRTRSCDSPAP | 561 | Q13591 | |
| GCAKAESGPASLTIC | 931 | P36956 | |
| LPLSCGSGKESRCCS | 916 | Q9H2X0 | |
| GSGKESRCCSRCTAH | 921 | Q9H2X0 | |
| CGDRCPSCAKVEGFS | 1281 | O75443 | |
| PRSCCKSIGSVSCDG | 176 | Q9UKR8 | |
| SGASVPGKTFCCGIC | 541 | P0CJ78 | |
| RSHTGEKPCRCSECG | 571 | Q96SZ4 | |
| CGRCLPSACEVVTGS | 2491 | P04275 | |
| APCPSCGKSCRSRAA | 366 | Q96BV0 | |
| CSTGKSLATLCDGPC | 166 | Q08629 | |
| NCSAVADTRCGCKPG | 106 | Q93038 | |
| TSTLGSCPERCAAVC | 181 | Q93038 | |
| CCSSSICEEGDGPRR | 441 | O60290 | |
| CVPISTSCCERGFKA | 1031 | O60290 | |
| TGKTPFVCSECGKSC | 341 | Q9GZX5 | |
| SRERCGVPFSCCTKD | 176 | P62079 | |
| IARACTSGDLPGCSC | 126 | O96014 | |
| TGKTPFVCTECGKSC | 451 | Q6PF04 | |
| CSTGRFTQGRQPCKC | 21 | Q8N446 | |
| PCVCSKCGKSFRGSS | 431 | Q96JF6 | |
| KTSRLLDGCGSLCCG | 336 | O00744 | |
| LRTTCKCHGVSGSCA | 206 | O14905 | |
| CCSCESPGDVLLSGR | 81 | Q6ZS46 | |
| CCNKGDCGTPSHSRR | 321 | P21754 | |
| KEISCGLSACCRGPL | 251 | Q8NFA0 | |
| NISTGLKPCECSICG | 181 | Q96BR6 | |
| CEECGKGFKCPSTLT | 511 | O75373 | |
| GFSIKGCRACRCSPL | 956 | Q9Y6N6 |